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Lucha de gigantes convierte 
el aire en gas natural. 
Un duelo salvaje advierte 
lo cerca que ando de entrar. 
En un mundo descomunal, 
siento mi fragilidad. 
Vaya pesadilla corriendo 
con una bestia detrás. 
Dime que es mentira todo, 
un sueño tonto y no más. 
Me da miedo la enormidad, 
donde nadie oye mi voz. 
Deja de engañar, 
no quieras ocultar 
que has pasado sin tropezar. 
Monstruo de papel, 
no sé contra quién voy, 
¿o es que acaso hay alguien más aquí? 
Creo en los fantasmas terribles 
de algún extraño lugar 
y en mis tonterías para  
hacer tu risa estallar. 
En un mundo descomunal, 
siento tu fragilidad. 
Deja de engañar, 
no quieras ocultar 
que has pasado sin tropezar. 
Monstruo de papel, 
no sé contra quién voy. 
¿O es que acaso hay alguien más aquí? 
Deja que pasemos 
sin miedo. 
 
 
Lucha de gigantes. Antonio Vega  
(versión de IZAL) 
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RESUMEN 
Esta tesis se enmarca dentro del campo de la radioterapia y trata específicamente sobre 
la radioterapia intraoperatoria (RIO) con electrones. Esta técnica combina la resección 
quirúrgica de un tumor y la radiación terapéutica directamente aplicada sobre el lecho 
tumoral post-resección o sobre el tumor no resecado. El haz de electrones de alta 
energía es colimado y conducido por un aplicador específico acoplado a un acelerador 
lineal. La planificación de la RIO con electrones es compleja debido a las 
modificaciones geométricas y anatómicas producidas por la retracción de estructuras y 
la eliminación de tejidos cancerosos durante la cirugía. Actualmente, no se dispone del 
escenario real en este tipo de tratamientos (por ejemplo, la posición/orientación del 
aplicador respecto a la anatomía del paciente o las irregularidades en la superficie 
irradiada), sólo de una estimación grosso modo del tratamiento real administrado al 
paciente. Las imágenes intraoperatorias del escenario real durante el tratamiento 
(concretamente imágenes de tomografía axial computarizada [TAC]) serían útiles no 
sólo para la planificación intraoperatoria, sino también para registrar y evaluar el 
tratamiento administrado al paciente. Esta información es esencial en estudios 
prospectivos. 
En esta tesis se evaluó en primer lugar la viabilidad de un sistema de seguimiento 
óptico de varias cámaras para obtener la posición/orientación del aplicador en los 
escenarios de RIO con electrones. Los resultados mostraron un error de posición del 
aplicador inferior a 2 mm (error medio del centro del bisel) y un error de orientación 
menor de 2º (error medio del eje del bisel y del eje longitudinal del aplicador). Estos 
valores están dentro del rango propuesto por el Grupo de Trabajo 147 (encargo del 
Comité de Terapia y del Subcomité para la Mejora de la Garantía de Calidad y 
Resultados de la Asociación Americana de Físicos en Medicina [AAPM] para estudiar 
en radioterapia externa la exactitud de la localización con métodos no radiográficos, 
como los sistemas infrarrojos). Una limitación importante de la solución propuesta es 
que el aplicador se superpone a la imagen preoperatoria del paciente. Una imagen 
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intraoperatoria proporcionaría información anatómica actualizada y permitiría estimar 
la distribución tridimensional de la dosis. 
El segundo estudio específico de esta tesis evaluó la viabilidad de adquirir con un TAC 
simulador imágenes TAC intraoperatorias de escenarios reales de RIO con electrones. 
No hubo complicaciones en la fase de transporte del paciente utilizando la camilla y su 
acople para el transporte, o con la adquisición de imágenes TAC intraoperatorias en la 
sala del TAC simulador. Los estudios intraoperatorios adquiridos se utilizaron para 
evaluar la mejora obtenida en la estimación de la distribución de dosis en comparación 
con la obtenida a partir de imágenes TAC preoperatorias, identificando el factor 
dominante en esas estimaciones (la región de aire y las irregularidades en la superficie, 
no las heterogeneidades de los tejidos). 
Por último, el tercer estudio específico se centró en la evaluación de varias tecnologías 
TAC de kilovoltaje, aparte del TAC simulador, para adquirir imágenes intraoperatorias 
con las que estimar la distribución de la dosis en RIO con electrones. Estos dispositivos 
serían necesarios en el caso de disponer de aceleradores lineales portátiles en el 
quirófano ya que no se aprobaría mover al paciente a la sala del TAC simulador. Los 
resultados con un maniquí abdominal mostraron que un TAC portátil (BodyTom) e 
incluso un acelerador lineal con un TAC de haz de cónico (TrueBeam) serían 
adecuados para este propósito.  
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ABSTRACT 
This thesis is framed within the field of radiotherapy, specifically intraoperative 
electron radiotherapy (IOERT). This technique combines surgical resection of a tumour 
and therapeutic radiation directly applied to a post-resection tumour bed or to an 
unresected tumour. The high-energy electron beam is collimated and conducted by a 
specific applicator docked to a linear accelerator (LINAC). Dosimetry planning for 
IOERT is challenging owing to the geometrical and anatomical modifications produced 
by the retraction of structures and removal of cancerous tissues during the surgery. No 
data of the actual IOERT 3D scenario is available (for example, the applicator pose in 
relation to the patient’s anatomy or the irregularities in the irradiated surface) and 
consequently only a rough approximation of the actual IOERT treatment administered 
to the patient can be estimated. Intraoperative computed tomography (CT) images of 
the actual scenario during the treatment would be useful not only for intraoperative 
planning but also for registering and evaluating the treatment administered to the 
patient. This information is essential for prospective trials. 
In this thesis, the feasibility of using a multi-camera optical tracking system to obtain 
the applicator pose in IOERT scenarios was firstly assessed. Results showed that the 
accuracy of the applicator pose was below 2 mm in position (mean error of the bevel 
centre) and 2º in orientation (mean error of the bevel axis and the longitudinal axis), 
which are within the acceptable range proposed in the recommendation of Task Group 
147 (commissioned by the Therapy Committee and the Quality Assurance and 
Outcomes Improvement Subcommittee of the American Association of Physicists in 
Medicine [AAPM] to study the localization accuracy with non-radiographic methods 
such as infrared systems in external beam radiation therapy). An important limitation 
of this solution is that the actual pose of applicator is superimposed on a patient’s 
preoperative image. An intraoperative image would provide updated anatomical 
information and would allow estimating the 3D dose distribution. 
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The second specific study of this thesis evaluated the feasibility of acquiring 
intraoperative CT images with a CT simulator in real IOERT scenarios. There were no 
complications in the whole procedure related to the transport step using the subtable 
and its stretcher or the acquisition of intraoperative CT images in the CT simulator 
room. The acquired intraoperative studies were used to evaluate the improvement 
achieved in the dose distribution estimation when compared to that obtained from 
preoperative CT images, identifying the dominant factor in those estimations (air gap 
and the surface irregularities, not tissue heterogeneities).  
Finally, the last specific study focused on assessing several kilovoltage (kV) CT 
technologies other than CT simulators to acquire intraoperative images for estimating 
IOERT dose distribution. That would be necessary when a mobile electron LINAC was 
available in the operating room as transferring the patient to the CT simulator room 
could not be approved. Our results with an abdominal phantom revealed that a portable 
CT (BodyTom) and even a LINAC with on-board kV cone-beam CT (TrueBeam) 
would be suitable for this purpose. 
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1 LIST OF ABBREVIATIONS 
2D  Two-dimensional 
3D   Three-dimensional 
AAPM  American Association of Physicists in Medicine 
ABS  Acrylonitrile butadiene styrene 
ASTRO  American Society for Radiation Oncology 
CBCT  Cone-beam computed tomography 
CT  Computed tomography 
CTV  Clinical target volume 
DNA  Deoxyribonucleic acid 
DTA  Distance-to-agreement 
DVH  Dose-volume histogram 
EBRT  External beam radiation therapy 
ELIOT  Electron intraoperative therapy 
EMTS  Electromagnetic tracking system 
FOV  Field of view 
FRE  Fiducial registration error 
GTV  Gross tumour volume  
Gy  Gray 
HA  Hydroxyapatite 
HDR  High-dose rate 
HU  Hounsfield units 
ICRP  International Commission on Radiological Protection 
ICRU   International Committee for Radiological Units 
IMU  Inertial measurement unit 
intraCT  Transformed intraoperative CT image 
IOERT  Intraoperative electron radiation therapy 
IORT  Intraoperative radiation therapy 
IR  Infrared 
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ISIORT  International Society of Intraoperative Radiation Therapy 
keV  Kilo-electron volt 
kV  Kilovoltage 
kVp  Kilovoltage peak 
LED  Light-emitting diode 
LINAC  Linear accelerator 
MOSFET Metal oxide semiconductor field-effect transistor 
MSCT  Multislice CT 
MeV  Mega-electron volt 
MV  Megavoltage  
OAR  Organ at risk 
OBI  On-board imager 
OR  Operating room 
OTS  Optical tracking system 
PDD  Percentage of depth dose 
PET  Positron emission tomography 
PLA  Polylactic acid 
PMMA  Polymethyl methacrylate 
POM  Polyoxymethylene 
preCT  Registered preoperative CT image 
preCTair   preCT with air gap 
preCTwater preCT assuming water 
PTV  Planning target volume 
RMS  Root mean square 
ROI  Region of interest 
RPM  Real-time position management 
SD  Standard deviation 
SI  International System of Units 
SPECT  Single photon emission computed tomography 
SSD  Source-to-surface distance 
TDP  Transverse dose profile 
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TG  Task group 
TOF  Time-of-flight 
TPS  Treatment planning system 
US  Ultrasound 
WBI  Whole breast irradiation 
WHO  World Health Organization 
XVI  X-ray volume imaging 
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2 MOTIVATION AND OBJECTIVES 
2.1 MOTIVATION 
Intraoperative electron radiation therapy (IOERT) is a technique that combines surgical 
resection of a tumour and therapeutic radiation directly applied to a post-resection 
tumour bed or to an unresected tumour. The procedure involves delivery of a single-
fraction, high electron radiation dose [1]. The electron beam is collimated and 
conducted by a specific applicator docked to a linear accelerator (LINAC). Dosimetry 
planning for IOERT is challenging owing to the geometrical and anatomical 
modifications produced by the retraction of structures and removal of cancerous tissues 
during surgery. Nowadays, radiation oncologists choose the treatment parameters 
during surgery according to the surgical scenario and clinical experience. Moreover, 
energy selection is based on dose profiles measured in water phantoms for different 
electron beam energies, applicator diameters and bevel angles. A further step in IOERT 
is the use of a specific treatment planning system (TPS) that enables simulating both 
the surgical procedure and the radiotherapy set-up with a preoperative computed 
tomography (CT) image [2, 3]. The treatment planning process includes delineating the 
target volume and organs at risk; simulating the expected incision, tumour resection 
and organ displacement; adding biological fluid accumulation, bolus materials, 
shielding discs and the applicator; and estimating the three-dimensional (3D) dose 
distribution. Patient position, surgical access, tumour resection and IOERT treatment 
set-up in the actual IOERT field can differ from those simulated in the TPS. Some 
studies have proposed the use of intraoperative images to check the alignment between 
the shielding disc, the applicator and the tumour bed in breast IOERT [4-6]. Moreover, 
in-vivo dosimetry would allow point and two-dimensional (2D) dose measurements   
[7-11]. However, no data of the actual IOERT 3D scenario is available (for example, 
the applicator pose in relation to the patient’s anatomy or the irregularities in the 
irradiated surface) and consequently only a rough approximation of the actual IOERT 
treatment administered to the patient can be estimated. For instance, some tissues in the 
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surgical cavity may interfere with applicator placement making the electron beam 
oblique to the irradiated surface and creating air gaps. A recent study has shown that 
curved irradiation surfaces caused dose distributions to be curved and deeper than those 
with flat surfaces [12]. Additionally, a cavity smaller than the applicator produced hot 
spots (high-dose regions) close to the surface followed by a fast dose reduction. 
Intraoperative CT images of the actual scenario during the treatment would be useful 
not only for intraoperative planning but also for registering and evaluating the 
treatment administered to the patient. This information is also essential for prospective 
trials. These CT studies would allow quantifying the improvement achieved in the dose 
distribution estimation when compared to that obtained from preoperative CT images.  
2.2 OBJECTIVES 
The main objective of this thesis is to propose and evaluate new approaches to improve 
the existing information on the actual IOERT treatment delivered to the patient.  
The specific objectives of this thesis are as follows: 
1. To study the feasibility of using a multi-camera optical tracking system (OTS) 
to obtain the applicator pose in IOERT scenarios. 
2. To assess the feasibility of acquiring intraoperative CT images in real IOERT 
scenarios and to evaluate the improvement achieved in the dose distribution 
estimation when compared that obtained from preoperative CT images. 
3. To evaluate several kilovoltage (kV) CT technologies that could acquire 
intraoperative images for estimating IOERT dose distributions. 
2.3 STRUCTURE OF THE DOCUMENT 
This document is divided in eleven chapters. Chapter 1 provides a list of abbreviations 
used throughout the document. Chapter 2 presents the motivation and the objectives of 
this thesis. Chapter 3 introduces IOERT with special attention to its limitations related 
to acquiring the actual treatment administered to the patient and also some other 
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concepts used throughout this thesis (for example, tracking systems). Chapter 4 focuses 
on the study about the feasibility of using a multi-camera OTS to obtain the applicator 
pose in IOERT scenarios (first specific objective of this thesis). Chapter 5 presents the 
study that assessed the feasibility of acquiring intraoperative CT images in real IOERT 
scenarios, and the difference between dose distributions estimated with intraoperative 
images (gold standard) and preoperative images (second specific objective of this 
thesis). Chapter 6 focuses on the evaluation of several kV CT technologies other than 
CT simulators to acquire intraoperative images for estimating IOERT dose 
distributions (third specific objective of this thesis). Chapter 7 presents a general 
discussion. Chapter 8 focuses on the main conclusions drawn from the studies 
presented in this thesis. Chapter 9 introduces some possible future lines of research 
derived from this thesis. Chapter 10 shows the author’s main publications. Finally, 
chapter 11 provides the references used throughout the document. 
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3 INTRODUCTION 
This chapter introduces intraoperative electron radiation therapy (IOERT), beginning 
with the interaction of electrons and its secondary particles with matter, the principles 
of IOERT, its characteristic dose distributions measured in water phantoms, some 
special considerations for dose estimation in patients (surgical cavity and 
heterogeneous tissues) and the advantages and limitations of a treatment planning 
system specifically designed for this radiotherapy treatment. Finally, some other 
concepts used throughout this thesis are also described, namely how to compare dose 
distributions, stoichiometric calibration and tracking systems.  
3.1 IOERT 
According to the World Health Organization (WHO), cancer was the second cause of 
death (8.2 million, 21.7%, in 2012 worldwide) among chronic diseases after 
cardiovascular diseases (46.2%) and followed by respiratory diseases (10.7%) and 
diabetes (4%) [13]. Moreover, the incidence was 14.1 million during 2012. The most 
common sites of those new cancer cases were lung, prostate, colorectum, stomach and 
liver cancer in men; and breast, colorectum, lung, cervix and stomach cancer in 
women. The tendency is that the number of new cancer cases will increase to 
22 million by 2022. Uncontrolled proliferation of cancer cells and their propagation to 
nearby tissues and, at the latest stages, to distant tissues is caused by an accumulation 
of deoxyribonucleic acid (DNA) alterations in genes that control cell division, cell 
growth, programmed cell death (apoptosis) and DNA repair [14]. DNA is the molecule 
that contains the genetic information to synthetise proteins with a specific cellular 
function. That growth of cancer cases is directly related to recent increase in life 
expectancy due to the accumulation of mutations in the DNA over time as a person 
gets older. According to WHO, prevention, early detection and patients’ management 
are the key factors to reduce and control cancer disease.  
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Traditional cancer treatments include surgical resection, chemotherapy and 
radiotherapy. The latter is based on applying ionizing radiation (radiation that has 
enough energy to eject electrons from atoms), usually in the form of photons (X-rays 
and gamma rays) or electrons. Radiobiological damage is caused by DNA ionization or 
by ionization of water contained in the cellular medium which in turn releases free 
radicals that react with DNA [15]. If damaged DNA cannot be repaired, cell death is 
produced mainly by mitotic catastrophe or apoptosis. Radiosensitivity is related to cell 
proliferation. Rapid cell division is a typical behaviour of cancer cells but also of bone 
marrow cells, intestinal tissues, hair follicles and nails [16]. Therefore, radiotherapy 
does not differentiate between cancer cells and healthy cells.  
Intraoperative electron radiation therapy (IOERT) is a technique that combines surgical 
resection of a tumour and therapeutic radiation directly applied to the post-resection 
tumour bed or to the unresected tumour. The procedure involves delivery of a single-
fraction, high electron radiation dose [1]. That radiation is collimated and conducted by 
a specific applicator docked to a linear accelerator (LINAC) (Figure 1). IOERT is not 
the only approach in intraoperative radiation therapy (IORT) as other alternatives are 
high-dose rate [HDR] brachytherapy (radioactive sources that emit gamma radiation) 
and low-kilovoltage (kV) X-ray technologies such as Intrabeam system (50 kV, Carl 
Zeiss Meditec AG, Germany) and Axxent MPX system (20–50 kV, Xoft Inc., USA, 
electronic brachytherapy). However, IOERT allows treating deeper volumes than HDR 
brachytherapy or low-kV X-ray technologies (up to 0.5–1.0 cm from applicator surface 
for the latter technologies) with a more homogeneous dose distribution [17]. 
IOERT enables direct visualization of the target volume. In addition, shielding or 
displacement of adjacent tissues and organs makes it possible to increase the dose to 
the target volume (range of 10–20 Gy) while minimizing the risk of irradiating healthy 
tissue [18]. The target volume in IOERT is the tumour bed (that presents high 
probability of residual cancer cells) or the macroscopic residue in the case of an 
unresected tumour. IOERT may also act against the mechanism of accelerated 
repopulation of tumour cells after surgery [1]. Moreover, after a surgery, tissues are 
more sensitive to radiation effect due to rich vascularization (oxygen effect) [19].  
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Figure 1. IOERT with a dedicated mobile LINAC.  
The first IOERT cases were performed at the University of Kyoto in 1965 after the 
installation of a betatron, which generated electron beams, in an operating room (OR) 
[1]. The interest for this technique has waxed and waned over the years. For example, 
IOERT became popular in Japan, United States and Europe in the late 1970s and early 
1980s. After that, its interest waned and then waxed again in the late 1990s with the 
development of mobile LINACs and the use of IOERT in breast cancer cases [20]. One 
reason why IOERT has not been widely adopted is its complexity, which challenges 
the involved multidisciplinary team of surgeons, radiation oncologists, 
anaesthesiologists, medical physicists, nurses, radiotherapy technicians and 
pathologists. This technique requires a close coordination between professionals of 
different disciplines to understand each other’s requirements [21]. 
Breast and rectum represent the most common IORT sites (63.8% and 15.9% 
respectively, database registry of the European section of the International Society of 
Intraoperative Radiation Therapy [ISIORT-Europe] up to 2011 [22]). Other sites 
include, for example, retroperitoneal and limb soft tissue sarcomas, prostate, pancreas, 
or oesophagus. The aim of IOERT is to improve control of the tumour site (local 
control) [23]. IORT combined with other cancer treatments such as external beam 
radiation therapy (EBRT) and chemotherapy seems to improve local control in many 
cancer sites compared to not including IORT in those scenarios [24].  
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IOERT is used in conjunction with fractionated EBRT (photons) or as a single dose. 
The former corresponds to a boost on the target volume for local dose escalation. For 
instance, in early-stage breast cancer, an IOERT single dose (an accelerated partial 
breast irradiation approach) enables reducing radiotherapy time (from 5–6 weeks for 
postoperative whole breast irradiation (WBI) with EBRT to a single high dose with 
IOERT) [25] and patient’s travel. Regarding disease control in this scenario, a 
randomised trial (electron intraoperative therapy [ELIOT] trial) revealed a significant 
difference of 5-year recurrence rates between postoperative WBI and IOERT single 
dose (0.4% and 4.4% respectively, ipsilateral breast tumour recurrences) while overall 
survival was identical (96.9% and 96.8% respectively) [26]. These results do not show 
that IOERT is as effective as postoperative WBI. The authors pointed out the difficulty 
when delimiting the suitable coverage of the tumour bed for those IOERT cases. On 
the other hand, the 5-year recurrence rates were better (1.5%) with a specific subset of 
patients (low-risk ELIOT group) [27]. Therefore, IOERT could be an alternative to 
postoperative WBI but with a proper selection of patients. Long-term results will allow 
assessing late side effects and outcome.  
3.2 INTERACTIONS OF ELECTRONS WITH MATTER 
Electrons may interact with atomic orbital electrons or atomic nuclei when passing 
through matter due to Coulomb forces. These interactions can be inelastic collisions 
(loss of kinetic energy) or elastic collisions (negligible loss of kinetic energy). A high-
energy electron undergoes multiple interactions with matter compared to a high-energy 
photon (for example, approximately 100000 interactions for an electron beam of                           
3 mega-electron volt [MeV]). In this process, its trajectory changes (scattering) and it 
slows down following a convoluted path until all its kinetic energy is released and the 
surrounding atoms capture it [28]. In fact, electron range is much shorter than its path 
length.  
When an electron interacts with an orbital electron, it changes its direction and gives up 
kinetic energy to that orbital electron, which can jump to a shell further from the 
nucleus (excitation) or be removed from the atom (ionization). In an excitation event, 
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the atom usually returns to stability after one or more electron transitions, emitting 
characteristic X-rays. In an ionization event, the ejected electron is known as secondary 
electron if it has enough kinetic energy to further ionise. If the orbital electron is in an 
outer shell, its binding energy is very low and the loss of kinetic energy in that 
interaction is negligible (thus the total kinetic energy of the scattered electron and the 
ejected electron is equal to the kinetic energy of the incident electron before the 
interaction). In this case, the collision is considered as elastic.  
When an electron interacts with a nucleus, the electron is deflected due to proton 
attraction. In the case of an inelastic interaction (more probable electron-nucleus 
interaction [28]), the total kinetic energy of the scattered electron and the recoil nucleus 
differs from the electron kinetic energy before the interaction. The loss of electron 
kinetic energy involved in this slowing-down process is converted to a photon. This 
mechanism is known as bremsstrahlung or “braking radiation”. The photon energy 
varies from 0 to the energy of the incident electron. This electromagnetic radiation 
mainly follows a right angle to the electron direction in the case of lower electron 
energies while the angle decreases for higher electron energies. 
In a medium of low atomic number (for example, water or tissue) electrons lose its 
kinetic energy mainly by excitation and ionization. By contrast, in a medium of high 
atomic number (for example, lead or tungsten) bremsstrahlung production is a more 
likely interaction. For example, in photon radiotherapy, high-energy X-rays are usually 
generated by bombarding materials of high atomic number with a beam of high-energy 
electrons. The mass stopping power (the average energy loss per traversed distance and 
per material density) includes the energy loss due to ionization and excitation 
(collisional loss) and the energy loss due to bremsstrahlung (radiation loss). The mass 
stopping power due to collisional losses increases for materials of low atomic number 
because materials of high atomic number have fewer electrons per gram (electron 
density) and those electrons are more tightly bound. On the other hand, the mass 
stopping power due to radiation losses increases with atomic number and electron 
kinetic energy (Figure 2). The rate of energy loss is about 2 MeV/cm in water or soft 
tissue [29].  
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The electron beam is scattered by, mainly, interactions with the nuclei [29]. The mass 
scattering power is the mean square scattering angle per traversed distance and per 
material density. This parameter increases with atomic number and decreases with 
higher electron kinetic energy [30]. Low-energy electrons are more likely to deflect 
following larger scattering angles. 
 
Figure 2. Mass stopping power for water, aluminum and lead materials. Values for collisional losses 
(narrow lines) and values for radiation losses (thick lines). Source [30]. 
As previously mentioned, the interaction of high-energy electron beams with matter 
produces ionizations (free electrons apart from those of the electron beam) and photons 
(characteristic X-rays and bremsstrahlung). This electromagnetic radiation, in turn, also 
interacts with matter by means of the following processes: coherent (Rayleigh) 
scattering, photoelectric effect, incoherent (Compton) scattering, pair production and 
photodisintegration. In Rayleigh scattering, photoelectric effect and Compton 
scattering, the incident photon interacts with an atomic orbital electron while in pair 
production and photodisintegration the photon interaction is with the electromagnetic 
field of an atomic nucleus. The details of these processes are as follows: 
 In Rayleigh scattering, the atom absorbs an incident photon, emitting 
afterwards a second photon with the same energy as the incident photon but in 
a different direction. This interaction is more common in materials of high 
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atomic number and with photons of very low energy (not enough to ionise the 
atom).  
 In photoelectric effect, the atom absorbs an incident photon with enough 
energy to ionise it. The kinetic energy of the ejected electron (called 
photoelectron) is equal to the difference between the photon energy and the 
electron binding energy. The vacancy created in the involved inner shell is 
filled by an electron of an outer electron shell. The electron energy lost in that 
process is emitted as characteristic X-rays. Photoelectric effect is predominant 
in materials of high atomic number and with photons of low energy                  
(kilo-electron volt [keV] range).  
 Compton scattering is similar to photoelectric effect but, in this case, the 
ejected electron is located in an outer shell. Another scattered photon of less 
energy is also emitted since the electron binding energy is much lower than 
the incident photon energy. This interaction is independent of the atomic 
number and is more common at intermediate energies (high keV to low MeV 
range).  
 In pair production interaction, the atom absorbs an incident photon creating an 
electron and a positron. Both particles share the energy of the incident photon 
minus the energy needed to create the electron-positron pair (1.02 MeV, twice 
the rest mass energy of an electron). A positron is the electron antiparticle 
(same mass as the electron but opposite charge) and loses its kinetic energy as 
an electron does. The difference is that, at the end of its range, the positron 
collides with an electron of an outer shell and both particles are destroyed, 
emitting two 511 keV gamma rays which travel in opposite directions 
(annihilation process). Pair production is more common at higher energies 
(high MeV range) [15].  
 In photodisintegration, the nucleus suddenly absorbs the incident photon 
emitting neutrons, which in turn also ionise matter, and gamma rays. This is 
the main reason for neutron contamination in high-energy accelerators for 
radiotherapy. This interaction occurs at very high photon energies (greater 
than 10 MeV) with materials of high atomic number.  
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Charged particles (for example, electrons and protons) are directly ionizing radiation 
since many ionization events occur along a particle path while uncharged particles (for 
example, photons and neutrons) are indirectly ionizing radiation since these particles 
do not produce multiple ionization events. In fact, their secondary charged particles 
generated are responsible of this process. 
3.3 ELEMENTS OF AN IOERT PROCEDURE 
The electron beam is accelerated to the high energies used in IOERT (4–20 MeV [17]) 
in a LINAC. The electrons gain energy by interacting with high-frequency 
electromagnetic waves (microwave range) in a linear tube. The high-energy electron 
beam is a narrow pencil beam (about 3 mm in diameter) when exiting the window of 
the accelerator tube. Then, the electron beam is spread with an electron scattering foil 
located in the treatment unit head (Figure 3). This device is a thin metallic foil of high 
atomic number to reduce the X-ray contamination (bremsstrahlung) of the electron 
beam. The electron scattering foil is also used to get uniform electron fluence in the 
treatment field (cross section). After that, the electron beam strikes an ion chamber to 
monitor dose delivery. Collimators and the electron applicator attached to the treatment 
unit head are used to confine the electron beam towards the treatment field within the 
surgical area since electrons easily scatter in air at energies lower than 15 MeV [31]. 
These devices are designed to, at least, maintain the beam flatness. The different 
elements in the treatment unit head, the applicator, air and the patient interact with the 
electron beam spreading its almost monoenergetic spectrum showed before exiting the 
window of the accelerator tube and contaminating it with X-rays (bremsstrahlung) [32].  
IOERT is carried out with a conventional LINAC routinely used for EBRT or with a 
dedicated mobile LINAC. In the former case, the X-ray target (material of high atomic 
number where the high-energy electron beam strikes to produce Bremsstrahlung 
X-rays) used in the photon mode of the LINAC operation is removed during IOERT. In 
addition, the flattening filter (device to get a uniform photon beam intensity across the 
field) is replaced with the electron scattering foil (Figure 3). In such IOERT scenario, 
the anaesthetised patient is transferred from OR to the LINAC room (bunker) for 
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irradiation and after that, to the OR again for surgical closure. Moreover, EBRT 
treatments must be interrupted during radiation delivery in IOERT. Dedicated mobile 
LINACs eliminate the need of patient’s transportation as these devices can be moved 
inside the OR for patient’s irradiation (Figure 1). LIAC, Novac (Sordina IORT 
Technologies S.p.A, Italy) and Mobetron (IntraOp Medical Corporation, USA) are 
examples of such devices. These miniaturised LINACs generate only electron beams 
(up to 12 MeV) and do not include bending magnets (required when the direction of 
the electron beam coming from the accelerator tube must be modified) that would 
produce X-ray leakage. X-ray and neutron leakage from the accelerator head, electron 
leakage from the applicator and bremsstrahlung produced in the patient are low enough 
according to radiation protection requirements to use these machines inside an OR 
without permanent shielding [20]. In these devices, the dose rate is high because their 
source-to-surface distance (SSD) is shorter than those in conventional LINACs, so 
irradiation time is considerably reduced (about 10 times faster, less than 1 minute for a 
dose of 21 Gy) [4, 33].  
 
Figure 3. Treatment unit head configuration of a LINAC. Source [29]. 
In a hard-docking device, the applicator system consists of two parts that are rigidly 
connected before the delivery of the radiotherapy treatment:  
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 Cone: a hollow cylinder that is attached to the treatment unit head. 
 Bevel: another hollow cylinder (same diameter as the cone) with a flat-end or 
bevelled end that is in contact with the patient’s surface (over the tumour bed 
or the residual tumour). This part also functions as a retractor of healthy 
tissues [34].  
On the other hand, Mobetron IOERT LINAC is a soft-docking system, where the 
applicator consists of one part with circular, elliptical or rectangular section to better fit 
the irradiated surface. Central axes of both applicator and LINAC are aligned with 
lasers [20]. 
In IOERT, internal shielding plates are used to minimise the risk of irradiating critical 
tissues that cannot be displaced enough. For example, in breast IOERT scenarios a 
shielding disc is placed between the pectoralis major muscle and the mammary gland 
to protect the underlying structures (ribs, lungs, heart) during irradiation (Figure 4). 
The thickness of this protection and its area depend on the electron beam energy to be 
absorbed and the field size respectively. Shielding discs are commonly made of lead. 
However, this material produces bremsstrahlung and backscatter electrons due to its 
high atomic number, and, in turn, enlarges the dose at the interface between tissue and 
lead in the upstream direction of the incident beam. This overdosage may cause 
unnecessary complications to the mammary gland above the shielding disc. Electron 
backscatter increases with materials of higher atomic number and decreases with higher 
energies. A two-layered disc approach is preferred to avoid this problem, where 
another shielding disc of low atomic number (first disc, for example, aluminum, 
polymethyl methacrylate [PMMA] or Teflon) is positioned above the disc of high 
atomic number (second disc, for example, lead, copper or stainless steel) and towards 
the residual breast to absorb the backscattering radiation (Figure 4). The alignment 
between the shielding discs and the tumour bed is partially checked with a needle when 
measuring the thickness of the target volume due to the lack of direct visual disc 
inspection. 
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Figure 4. Breast IOERT set-up with the margins of the tumour bed temporarily approximated with 
sutures (left, adapted from [25]) and an example using a two-layered disc approach                                  
(right, adapted from [35]). 
3.4 DOSE DISTRIBUTIONS FOR ELECTRON BEAMS 
The dose is defined as the energy absorbed from the radiation beam per unit mass of 
the irradiated tissue and is measured in Gray (Gy, International System of Units [SI]), 
which is the absorption of one joule of radiation energy per kilogram of matter. It 
includes the energy involved in ionization and excitation processes. Dose estimation is 
commonly based on ionization measurements. The amount of cell killing increases 
when a tumour receives a higher dose [18]. Maximum IOERT doses tolerated by 
normal tissues are tissue dependent. For example, peripheral nerve tolerates less dose 
than bones.  
Percentage of depth dose (PDD) profiles, their transverse dose profiles (TDPs) at 
certain depths (also called off-axis profiles or cross plane profiles) and isodose curves 
are commonly used to represent three-dimensional (3D) dose distributions. PDD is the 
profile along the clinical axis (the vector normal to the irradiated surface that intersects 
the bevel centre [Figure 5]) [21]. This axis is clinically important because the depth 
from the irradiated surface is relevant in IOERT. The clinical axis matches the 
geometric axis of the applicator (the central axis or longitudinal axis of the applicator) 
for non-bevelled applicators (bevel angle 0º). 
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Dose distributions are measured in water phantoms and depend on the electron beam 
energy, the treatment machine (for example, due to the elements to flatten and 
collimate the beam), the applicator diameter and its bevel angle.  
 
Figure 5. Clinical and geometric axes of the applicator. Thickness of the air gap between the bevel and 
the irradiated surface (g), depth at which the dose is maximum (dmax), bevel angle of the applicator (θ) 
and source-to-surface distance (SSD). Adapted from [21].  
  
Figure 6. Dose profiles for an electron beam in water medium. PDD (left, adapted from [36]) and                                  
TDP (right, source [37]). Ap (applicator diameter). 
Figure 6 displays a PDD of an electron beam in water medium. This curve shows a 
typical sharp falloff of dose at distances beyond a certain depth. A PDD is 
characterised by the following parameters [36]: 
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 Ds is the dose measured at 0.5-mm depth (surface dose).  
 Dm is the maximum dose and is measured at depth R100. The build-up region is 
the region between the surface and depth R100. 
 Dx is the dose due to X-ray contamination (bremsstrahlung tail). This 
parameter increases with the energy of the electron beam (Figure 7).  
 Rt or therapeutic range is the clinically useful range. According to the 
recommendations of Task Group 25 (TG–25) of the Radiation Therapy 
Committee of the American Association of Physicists in Medicine (AAPM), 
Rt is the depth of the deepest 90% dose. In a water medium, this value (in mm) 
is roughly one-fourth of the nominal energy of the electron beam (in MeV) 
[32].  
 Rp or practical range is the intersection between the bremsstrahlung tail and 
the tangent to the PDD curve (falloff portion) at the inflection point. The most 
probable energy of the radiation beam at the surface depends on Rp. The 
maximum range of the electrons is the intersection between the 
bremsstrahlung tail and the PDD curve.  
 Finally, Go or normalised dose gradient measures the steepness of the falloff 
portion, where Rq is the depth at which the previous tangent is intersected by 
the level Dm. 
Surface dose, bremsstrahlung dose and therapeutic range become larger when 
increasing the energy of the electron beam (less scattering in the surface and the 
electron beam penetrates deeper). An opposite effect occurs with the dose gradient 
(Figure 7). Moreover, surface dose is larger for an electron beam than for a photon 
beam (Figure 7). Dose gradient has that same behaviour as surface dose due to 
scattering and the continuous energy loss of the electrons. PDD also depends on the 
field size (applicator diameter) as depicted in Figure 8 due to lateral scattering of 
electrons. This effect is more pronounced when increasing the energy of the electron 
beam. The depth of maximum dose moves towards the surface when the field size 
decreases. 
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Figure 6 shows a TDP in water medium with a typical region of homogeneous dose. 
The flatness and symmetry of the beam are also measured over the central 80% of this 
dose profile at a stated depth (water phantom). The physical penumbra is commonly 
determined as the distance between the 80% and 20% dose, measured in TDP at depth 
଼ܴହ/2 where ଼ܴହ is the depth of the deepest 85% dose on the electron beam central 
axis (International Committee for Radiological Units [ICRU] recommendation) [32]. A 
higher energy of the electron beam decreases the penumbra at the surface as the 
electron beam is less scattered in air. The air gap between the bevel and the irradiated 
surface affects less in this case. The opposite behaviour occurs at the therapeutic range 
due to multiple scattering: a higher energy increases the penumbra at that depth [36]. 
 
Figure 7. Comparison of the PDD of an electron beam (left) and the PDD of a photon beam. In both 
cases, reference field size for clinical electron beam dosimetry (10 × 10 cm) and SSD of 100 cm. 
Adapted from [32]. 
 
Figure 8. Variation of PDDs of an electron beam with field size and energy. Source [29]. 
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An isodose chart is a set of lines passing through points of the same dose (isodose 
curves) and represents the dose variation as function of depth and off-axis distance. 
The isodose curves spread with depth and curves of a isodose level lower than 20% 
swell due to scattering [32]. Figure 9 shows the different shape of the isodose curves 
when using a bevelled applicator. The beam obliquity moves the depth of maximum 
dose towards the surface, increases the latteral scattering at that depth and decreases the 
depth of the 80% dose [29]. 
 
Figure 9. Isodose curves measured in solid water phantom with Gafchromic fi lm (9 MeV electron 
beam). Applicator diameter of 8 cm and bevel angle of 0º (left) and of 45º (right). Source [12]. 
3.5 COMPARISON OF DOSE DISTRIBUTIONS 
A quantitative comparison of two dose distributions (namely a reference dose 
distribution or gold standard and an evaluated dose distribution) may be carried out by 
means of calculating the dose difference between both distributions. However, regions 
of high dose gradient may lead to wrong conclusions as small spatial errors may 
produce large dose differences. An alternative approach is the gamma distribution that 
combines dose differences with the distance-to-agreement (DTA) concept that is the 
distance between a point from the reference dose distribution and the nearest point in 
the evaluated dose distribution with the same dose as that of the reference point. This 
method is based in calculating for each point in the reference dose distribution (3D 
coordinates ࢘௥) the following quality index gamma (γ) [38]: 
γሺ࢘௥ሻ ൌ ݉݅݊ሼ߁ሺ࢘௥, ࢘௘ሻሽ ∀ ࢘௘ 
 
(1) 
 
where ࢘௘  are the 3D coordinates of a point in the evaluated dose distribution and  
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߁ሺ࢘௥, ࢘௘ሻ ൌ ඨ൫ܦ௥
ሺ࢘௥ሻെܦ௘ሺ࢘௘ሻ൯ଶ
∆ܦଶ ൅
|࢘௥െ࢘௘|ଶ
∆݀ଶ  
(2) 
 
where ܦ௥ሺ࢘௥ሻ is the dose in the reference dose distribution at the point ࢘௥, ܦ௘ሺ࢘௘ሻ is 
the dose in the evaluated dose distribution at the point ࢘௘, and ∆ܦ and ∆݀ are the 
passing criteria for dose and distance respectively. At point ࢘௥, the evaluated dose 
distribution is similar to the reference dose distribution if γሺ࢘௥ሻ ൑ 1. For 
two-dimensional (2D) dose distributions, this criterion is equivalent to draw an 
ellipsoid (semi-principal axes of length ∆ܦ, ∆݀ and ∆݀) centred at coordinates 
(ܦ௥, ݔ௥, ݕ௥) and check if there is at least one evaluated point of coordinates (ܦ௘, ݔ௘, ݕ௘) 
that is inside or on that ellipsoid (Figure 10). 
 
Figure 10. Geometric representation of γሺr୰ሻ ൑ 1. Adapted from [38]. 
Gamma distribution is the mainstay of dose distribution comparisons in medical 
physics. An acceptance criteria of 3% dose difference (∆ܦ) and a 3-mm DTA (∆݀) 
(commonly referred to as gamma criteria of 3%/3 mm) for dose values greater than 
10% is widely used in intensity-modulated radiation therapy [39]. The disadvantages of 
gamma index are that is dimensionless (for example, a dose difference is more 
clinically intuitive), signless (thus no information about if the reference dose 
distribution at point ࢘௥	is higher or lower than the evaluated dose distribution), and 
sensitive to dose grid resolution and to interchange between reference and evaluated 
dose distributions. An alternative approach is proposed in [40] where the authors 
introduce a dimension and sign index to compare dose distributions. That index 
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corresponds to a 3D dose difference weighted by dose gradient and previous passing 
criteria (∆D and ∆d). 
3.6 SPECIAL CONSIDERATIONS IN IOERT 
In IOERT treatment, radiation oncologists choose the treatment parameters (applicator 
diameter, bevel angle, applicator pose [position and orientation] and prescribed dose at 
a certain depth) during surgery according to the surgical scenario and clinical 
experience. The applicator diameter is selected to include the whole tumour bed or the 
residual tumour plus a safety margin while the bevel angle allows maximising dose 
homogeneity in sloping surfaces. The dose depends on the amount of residue [41]. For 
instance, in breast cancer treatments, the radiation oncologist usually measures the 
thickness of the target volume with a needle and a ruler. This process is done after 
firstly, placing the shielding disc and then, temporarily approximating the margins of 
the tumour bed with sutures. This information is given to medical physicists that 
choose an appropriate beam energy so that a certain percentage isodose (commonly, 
90% isodose line), at which dose is prescribed, encompasses the target volume. Energy 
selection is based on dose profiles measured in water phantoms for different electron 
beam energies, applicator diameters and bevel angles. 
IOERT treatments are based on several assumptions: the irradiated tissue is equivalent 
to water in both stopping power and scattering power, and the bevel is in contact with 
the patient’s surface (thus the end of the applicator is parallel to the surface). However, 
the patient’s anatomy includes heterogeneous tissues such as air, lung and bone that are 
not water-equivalent. Moreover, some tissues in the surgical cavity may interfere with 
applicator placement making the electron beam oblique to the irradiated surface and 
creating air gaps. Furthermore, surfaces may be irregular and biological fluid can 
accumulate in the surface as a result of the surgical procedure after resecting the 
tumour. These factors alter the dose distribution typical of water medium as follows: 
 The penetration of the electron beam is larger in lungs, having higher doses 
than expected.  
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 In a small (related to field size) low-density heterogeneity, electron scattering 
towards this inhomogeneity is more probable than the opposite. Hot spots are 
produced in the dose distribution immediately under the heterogeneity and 
cold spots are also created lateral to that inhomogeneity due to the fluence 
perturbation. An opposite effect occurs in the case of a small high-density 
heterogeneity [42].  
 Scatter produced by sharp irregularities in the irradiated surface also produces 
hot or cold spots in the underlying tissues, having overdose or underdose in 
some tissues respectively (Figure 11). In these surfaces, the electrons are 
mainly scattered outwards by steep projections [29]. A bolus may be placed 
on the area to be irradiated to try to reduce these problems as it can smooth 
sharp edges and flatten an irregular surface in addition to increase surface 
dose. Bolus requirements are flexibility to shape into the patient’s surface and 
tissue equivalence in both stopping power and scattering power. 
 An underdosage of the target volume may result from, for example, a fluid 
accumulation of 1.0–1.5 cm. Suction is recommended for reducing fluid 
build-up [20].  
 
Figure 11. Isodose curves for an electron beam and sharp surface irregularities. Adapted from [29]. 
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There are some dose corrections for air gaps (such as that displayed in Figure 12) and 
for specific tissue inhomogeneities that are applied in electron EBRT [29]. However, 
these corrections are not suitable for IOERT as a surgical cavity is more complex and 
its actual surface shape is unknown. Moreover, estimation of the dose distribution is 
difficult to achieve when having small heterogeneities due to electron scattering [29]. 
 
 
 
 
 
 
 
Figure 12. Example of an air gap between the applicator end and the irradiated curve surface. Dose of 
a point at depth d  is corrected based on the air gap of height g  and the angle θ. Adapted from [29]. 
AAPM Radiation Therapy Committee TG–72 pointed out that, in IORT, further 
research is needed to evaluate “the effects of beam misalignment, gaps, bolus, changes 
of penumbra and tissue inhomogeneities in realistic patient geometries” [43]. 
Following that recommendation, in [44] the authors showed the effect of the 
misalignment between the shielding disc and the applicator. The dose distribution in 
the target volume did not significantly vary with disc translation and disc rotation of up 
to 10º. However, a translation of the shielding disc equal to or greater than the 
difference between its radius and the internal radius of the applicator or a disc rotation 
of above 20º resulted in irradiation of healthy tissues. On the other hand, in [12] the 
authors simulated some characteristic pelvic IOERT scenarios (rectal cancer) with solid 
water slabs and radiotherapy bolus. The bevel commonly used in these cases is 45º 
while a non-bevelled applicator is mainly used in breast IOERT [22]. The irradiation 
surface is commonly irregular and/or concave in rectal IOERT. In addition, flatten 
pelvic IOERT surfaces is not easy compared to this task in breast cases. In that study, 
the authors showed that curved irradiation surfaces caused dose distributions to be 
curved and deeper than those with flat surfaces. Moreover, a cavity smaller than the 
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applicator produced hot spots close to the surface followed by a fast dose reduction 
(Figure 13). That group presented in vivo 2D dose distributions for pelvic IOERT with 
Gafchromic EBT3 films (radiochromic films), showing different results along the 
irradiated surface which did not correspond to expected values (Figure 14) [10]. The 
authors also underlined the influence of fluid build-up and the presence of surface 
hotspots due to step-like irregularities. Therefore, the actual scenario is important in 
IOERT to calculate doses more accurately. 
 
 
 
 
Figure 13. IOERT dose distributions for curved irradiation surfaces measured with Gafchromic EBT3 
film (9 MeV electron beam). Simulated surgical cavity with solid water slabs and radiotherapy bolus 
(left), isodose curves for an applicator of 6-cm diameter and bevel angle of 45º (centre) and isodose 
curves for an applicator of 8-cm diameter and bevel angle of 45º (right). Adapted from [12]. 
 
Figure 14. In vivo 2D dose distributions for pelvic IOERT measured with three Gafchromic EBT3 fi lms 
located on each irradiation surface. From left to right, IOERT scenario and results from Gafchromic 
EBT3 films placed on the surface at R-3.4cm (Dm inf.), R (Dm cent.) and R+3.4cm (Dm sup.), where R 
is the bevel centre. Expected positioning uncertainty of ± 1 cm. The left side in the photograph 
corresponds to the longest edge of the applicator (deeper position [inf.]). From top to bottom, case 1 
with an applicator diameter of 8 cm and bevel angle of 0º (expected surface dose at R: 13.9 Gy) and 
case 2 with an applicator diameter of 9 cm and bevel angle of 45º (expected dose at R : 13.8 Gy). In 
both treatments, the energy of the electron beam was 9 MeV. Case 1 was identified as the only flat 
surface in this study with good agreement between the dose of the central fi lm and its expected value. 
Dm sup. (case 1) was likely in the penumbra region. The higher dose in Dm inf. (case 2) was probably 
due to fluid build-up. Adapted from [10].  
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3.7 TREATMENT PLANNING SYSTEM 
The first step in EBRT (photons) is the simulation step where a specific patient’s 
computed tomography (CT) image is acquired in a CT simulator. That device is a 
dedicated radiation oncology CT scanner with a larger bore than a conventional 
diagnostic CT scanner, a flat table similar to that of a radiotherapy treatment machine 
and a laser positioning system. A CT simulator enables acquiring the patient in the 
same position as during the radiotherapy treatment (for example, including special 
immobilization devices). The treatment planning process starts loading that study and 
other patient’s useful images (prior CT, magnetic resonance or positron emission 
tomography [PET] studies) into a treatment planning system (TPS) to delineate the 
gross tumour volume (GTV, i.e. the visible tumour volume), the clinical target volume 
(CTV, i.e. GTV plus a margin for subclinical tumour spread), the planning target 
volume (PTV, i.e. CTV plus a margin that takes account of set-up inaccuracy and 
organ movements) and organs at risk (OARs) [45]. After that, the optimal treatment 
parameters (patient’s position relative to the radiation source, number of treatment 
fields, collimator shape and photon energy) are selected in the TPS. Then, the dose 
delivered to target and critical volumes is estimated based on the study acquired in the 
CT simulator, the conversion between Hounsfield units (HU) and density, and the 
knowledge of the interactions of photon beams with body tissues (forward planning). 
Finally, the estimated dose distribution can be visualised directly on the patient’s 
anatomy (for example, CT image) and dose information such as cumulative dose-
volume histograms (DVHs) is also displayed. DVHs show the percentage of volume of 
a specific structure (target or OAR) that absorbs at least a certain dose (Figure 15). 
During every EBRT treatment session, patients are positioned in the treatment room by 
aligning skin tattoos or immobilization devices marked during the simulation step with 
in-room laser beams. Image guidance technologies such as orthogonal megavoltage 
(MV) or kV portal images, MV or kV cone-beam CT (CBCT), in-room CT, and 
ultrasound (US) are used to improve beam alignment with respect to the target volume 
[46]. 
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Figure 15. Ideal cumulative DVH (left) and a cumulative DVH for a prostate treatment plan (right). 
Ideally, the 100% of the target volume would receive the prescribed dose and the 0% of the critical 
structure volume would receive a dose different to 0 Gy. Source [47]. 
A further step in IOERT is the use of a specific TPS (RADIANCE, GMV, Spain) [2, 3] 
which allows estimating the IOERT dose distribution from a preoperative CT study. 
This software was developed in collaboration with Hospital General Universitario 
Gregorio Marañón (Madrid, Spain). This TPS enables delineating GTV, CTV (the 
tumour bed) and OARs on that CT image (Figure 16). PTV makes no sense in IOERT. 
Surgical access (the expected incision area), tumour resection and organ displacement 
can be simulated by filling these regions with air in the preoperative CT study. 
Moreover, biological fluid accumulation, bolus materials and shielding discs may also 
be incorporated in the IOERT plan. After that, the user selects a specific applicator 
diameter, bevel angle and energy of the electron beam, adjusting the pose of a virtual 
applicator with those specifications with the help of the orthogonal views (sagittal, 
coronal and axial) and the volume rendering view of that CT study. Then, the 3D dose 
distribution is estimated, taking account of tissue heterogeneities or assuming all 
tissues equivalent to water. Finally, the user can visualise isodose curves superimposed 
on patient’s preoperative image and further evaluate information from the 3D dose 
distribution such as PDD, TDPs and cumulative DVHs (Figure 16). This process 
allows the radiation oncologist to assess the changes in dose distribution when 
modifying the surgical cavity or IOERT parameters (energy of the electron beam, 
applicator pose, applicator diameter and bevel angle). The objective is to maximise the 
dose delivered to the target volume and minimise its effect on the OARs. 
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In IOERT TPS, 3D dose distributions are estimated by pencil beam [48, 49] or Monte 
Carlo algorithms [50] specifically adapted to this setting. Pencil beam is an analytical 
method based on the Fermi-Eyges theory that assumes that a broad electron beam 
consists of many pencil beams and the dose at a certain point is the combination of 
their contributions. The lateral spread of each pencil beam follows, approximately, a 
Gaussian function whose width increases with depth (Figure 17) [32]. This theory only 
takes account of small angle multiple Coulomb scattering [30]. A modified Hogstrom’s 
pencil beam used in EBRT, which takes account of other effects shown in the electron 
interaction with matter, was implemented in the IOERT TPS [3, 48, 49]. However, this 
method is subject to limitations with small irradiated volumes owing to the semi-
infinite layer approximation (Figure 17) and does not model backscatter radiation [49]. 
On the other hand, Monte Carlo is a more accurate statistical method that simulates the 
propagation step by step for each electron and its secondary particles produced 
according to electron-matter interactions. A fast parallel version of a Monte Carlo 
algorithm (dose planning method, DPM) that calculates dose distributions of photon 
and electron beams in radiotherapy was implemented in the IOERT TPS [3, 50]. 
 
Figure 16. Example of an IOERT planning (tumour in the abdominal area). From left to right, IOERT 
simulation (segmentations of tumour [GTV], tumour bed [CTV] and OARs [left kidney and spinal cord], 
and simulation of fluid accumulation and surgical access), virtual applicator and 3D dose distribution 
superimposed on patient’s anatomy, and DVH (CTV, left kidney, spinal cord and fluid). From top to 
bottom, axial view and volume rendering view. 
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In that TPS, the IOERT dose distribution takes account of patient’s anatomy 
(heterogeneous tissues), the surgical cavity, biological fluid accumulation in the 
surface, bolus and shielding discs. This TPS enables the radiation oncologist (with 
close interaction of the surgeon) to plan an IOERT treatment beforehand and to adapt it 
to intraoperative findings and manoeuvres during surgery. However, IOERT planning 
is based on a simulation of both the surgical procedure and the radiotherapy set-up with 
the preoperative CT image.  
 
Figure 17. Effect of the semi-infinite layer approximation (pencil beam algorithm). The lateral spread of 
each pencil beam is estimated from the material along its main axis at each depth. Some portions of 
the centred and right pencil beams are wrong due to the different density region. Source [51].  
Several studies have proposed the acquisition of intraoperative images to check the 
alignment between the shielding disc and the applicator/tumour bed in breast IOERT. 
These intraoperative approaches included 2D portal films (MV) [4], US images (also 
for measuring target depth) [6], X-ray images (acquired with a C-arm) [5] or 
Gafchromic films placed on shielding discs (for a posteriori analysis) [44]. On the other 
hand, in-vivo dosimetry with silicon diodes, metal oxide semiconductor field-effect 
transistors (MOSFETs), microMOSFETs and radiochromic films allows point and 2D 
dose measurements in an IOERT procedure [7-11]. However, no data of the final 
IOERT 3D scenario is available (for example, the applicator pose in relation to the 
patient’s anatomy or the irregularities in the irradiated surface) and consequently only a 
rough approximation of the real IOERT treatment administered to the patient can be 
estimated. In [52], the authors pointed out several breast IORT limitations including the 
lack of intraoperative imaging to check applicator placement and to calculate 3D dose 
distributions before radiation delivery. For instance, in IORT HDR brachytherapy, an 
in-room CT-on-rails was used to acquire patient’s CT images (after tumour resection 
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and placing a multicatheter brachytherapy balloon) to overcome those limitations [53]. 
Acquiring intraoperative CT images of the actual IOERT scenario may be necessary to 
evaluate the improvement achieved in the dose distribution estimation when compared 
to that obtained from preoperative CT images.  
Regarding IOERT documentation, the patient’s medical record includes applicator 
diameter; bevel angle; prescribed dose; its percentage isodose; electron beam energy 
(depth of prescribed dose); and, if used, characteristics of shielding plates and bolus. In 
addition, photographs of the IOERT scenario such as beam’s eye view are also taken. 
However, no intraoperative 3D images of the actual IOERT scenario are routinely 
acquired for accurate reconstruction of the irradiated volume. This information is 
essential for the assessment of clinical results [24]. For instance, underdosage or 
overdosage of the target volume and the OARs may produce local recurrence or side 
effects. 
3.8 STOICHIOMETRIC CALIBRATION 
Dose distribution is estimated based on a patient’s CT image (with all IOERT 
simulations such as surgical access, tumour resection, organ displacement, bolus and 
shielding dics), the conversion from HU to density and tissue/material type (specific 
for each CT simulator and acquisition parameters), the physical properties of the 
electron beam (specific for each treatment unit, energy and applicator), and 
tissue/material parameters. 
The calibration curve for the transformation of HU to density is estimated from images 
of an electron density phantom acquired in the same CT simulator and with the same 
acquisition parameters that will be later used when obtaining patient’s images. This 
phantom is made of tissue-equivalent materials that represent the densities of tissues 
but do not usually replicate their chemical composition. These differences lead to large 
dose deviations (for example, more than 30% for an 18-MeV electron beam [54]). 
Stoichiometric calibration is an approach to overcome this problem [55, 56]. Before 
explaining this method, some related concepts are detailed as follows. 
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The mean value of the linear attenuation coefficient μ of a tissue for an incident photon 
beam with a typical mean energy of 50–100 keV (diagnostic radiology) follows this 
expression [56]: 
̅ߤ ൌ 	ߩ ௔ܰ෍൤ݓ௜ܣ௜ ሺܼ௜ܭ
ഥ௄ே ൅ ܼ௜ଶ.଼଺ܭഥ௦௖௔ ൅ ܼ௜ସ.଺ଶܭഥ௣௛ሻ൨
ே
௜ୀଵ
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where ߩ is the (physical) density of the tissue, ௔ܰ is the Avogadro constant               
(6.022045 x 1023 mol-1), ܰ is the number of chemical elements that tissue contains, ݓ௜ 
is the weight proportion of the element ݅, ܣ௜ is its mass number (number of neutrons 
and protons in its nucleus), ܼ௜ is its atomic number (number of protons in its nucleus), 
ܭഥ௄ே is the Klein-Nishina coefficient (related to incoherent scattering [Compton]), ܭഥ௦௖௔ 
is a term related to coherent scattering (Rayleigh) and the binding correction for 
Compton, and ܭഥ௣௛ is a term related to photoelectric absorption [56]. These three last 
terms are spectral dependent. The mean value of the linear attenuation coefficient (̅ߤ) is 
converted to HU scale (the X-ray attenuation of distilled water and attenuation of air at 
standard pressure and temperature are defined as 0 HU and –1000 HU respectively) by 
applying the following equation: 
ܪ ൌ 1000ቆ ̅ߤ̅ߤுమை
െ 1ቇ 
 
(4) 
 
where ̅ߤுమை is the mean value of the linear attenuation coefficient for water. Therefore, 
ܪ ൌ 1000ቌ ߩߩுమை
ൈ
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where ߩுమை is the density of water, ܪ represents hydrogen, ܱ is oxygen, ݇ଵ ൌ ௄
ഥೞ೎ೌ
௄ഥ಼ಿ and 
݇ଶ ൌ ௄ഥ
೛೓
௄ഥ಼ಿ [56]. 
The stoichiometric calibration allows obtaining a conversion from HU to density 
adjusted to a set of tissues whose density and chemical composition are known. The 
first step of this method concerns computing the constants ݇ଵ and ݇ଶ of equation (5) by 
a constrained least squares fit of the HU measured in a CT image of the electron 
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density phantom. The following expression is minimised with the constraints                  
0 ൑ ݇ଵ ൑ 1 and 0 ൑ ݇ଶ ൑ 1: 
݂ሺ݇ଵ, ݇ଶሻ ൌ෍ቈ ̅ߤ௝
ሺ݇ଵ, ݇ଶሻ
̅ߤுమைሺ݇ଵ, ݇ଶሻ
െ ቆ ܪഥ௝1000 ൅ 1ቇ቉
ଶெ
௝ୀଵ
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where ܯ is the number of regions of interest (ROI) measured in the CT image of the 
electron density phantom and ܪഥ௝ is the mean HU measured in that ROI ݆. The density 
and chemical composition (and also weight proportion of each element) of the phantom 
materials are provided by the phantom manufacturer. Once constants ݇ଵ and ݇ଶ are 
estimated for the specific CT simulator and certain CT acquisition parameters, the 
expected HU of each tissue is calculated by applying equation (5). Finally, a calibration 
curve (density as function of HU) is obtained with a linear interpolation of those tissue 
data and then, is entered into the TPS for dose estimation. 
3.9 TRACKING SYSTEMS 
Tracking systems are used in clinical applications to determine the localization of the 
patient and specific tools inside the treatment room. This information is necessary for 
the navigation system to update the 3D pose of the corresponding virtual tools relative 
to the patient’s virtual anatomy (specifically, preoperative images and anatomical 
models) during an image-guided procedure. Preoperative images and anatomical 
models provide valuable information to identify a target in the patient. After a 
registration step that relates both real and virtual worlds, the navigation system helps 
the physician to reach that target with a specific tool, gives intraoperative orientation 
when no anatomical references are available and allows avoiding risk areas. By 
analogy with a GPS (global positioning system) navigation system, patient’s virtual 
anatomy is the road map, the target is the destination, the tracking system is the GPS, 
the specific tool is the car and the driver is the physician [57].  
Tracking technologies include acoustic tracking, mechanical tracking, inertial tracking, 
electromagnetic tracking and optical tracking. The best choice of tracking system 
depends on the clinical application, the working volume, whether or not it is necessary 
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to track inside the body, the tools to be tracked, the accuracy requirements, the update 
rate and space restrictions. Current commercial acoustic tracking systems are based on 
time-of-flight (TOF) where the distance is estimated from the time sound needs to 
travel from the transmitter to the receivers. Their disadvantages are inaccuracy and 
environmental dependence (for example, noise, reflections, media density, temperature 
and humidity). An example of mechanical tracking system would be a robotic arm that 
has a motor in each translational or rotational joint (or degree of freedom) and where 
the pose of the end effector is estimated with robot kinematics [58]. These systems are 
highly accurate and stable. Their disadvantages are motion interference and limited 
range due their dimensions. Moreover, one device cannot track multiple objects. An 
inertial measurement unit (IMU) can include three-axis accelerometers, three-axis 
gyroscopes and three-axis magnetometers [59]. Pose is estimated with double 
integration of acceleration and integration of angular velocity. This device has no range 
limitations but accumulates error over time. In an electromagnetic tracking system 
(EMTS), each sensor (specifically, coils) measures the magnetic field generated by a 
transmitter. The tracking system estimates the sensor pose based on the theoretical 
knowledge of the transmitted field. Finally, videometric and infrared (IR)-based 
tracking systems belong to optical tracking category. The former systems rely on 
identifying unique patterns or target objects in video image sequences captured with 
one or more digital cameras. On the other hand, IR-based systems use at least two 
cameras (stereo vision) to calculate the 3D coordinates of optical markers (active or 
passive) through triangulation. Each camera includes an IR pass filter in front of its 
lens to remove visible light. This modification makes marker identification easier than 
with a videometric tracking system. Active markers are light-emitting diodes (LEDs) 
that emit near-IR light and require a wire or battery to operate. Passive markers, on the 
other hand, are spheres with retro-reflective coatings that reflect near-IR light (coming 
from a ring of LEDs in every camera) back into the cameras. A specific pattern (called 
rigid body) of at least three non-collinear optical markers whose different relative 
distances do not vary over time is attached to the tracked tool so that the optical 
tracking system (OTS) can estimate its 3D pose. OTS is a popular tracking approach 
and offers a larger working volume and higher accuracy than EMTS. The difference in 
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accurary between both tracking technologies has been reduced. For example, the 
specifications of Aurora V2 EMTS (Northern Digital Inc. [NDI], Canada) point out an 
error of 0.48 mm root mean square (RMS) in position and 0.30º RMS in orientation 
(volume 50 x 50 x 50 cm, without electromagnetic disturbances) while those of Polaris 
OTS (NDI) detail an error of 0.30 mm RMS (extended pyramid, up to 1.9 x 1.5 x 3 m), 
(http://www.ndigital.com). EMTS sensors are smaller (up to 0.3 mm in diameter) but 
this type of tracking system is commonly wired and is potentially affected by large 
ferromagnetic objects [60-62]. On the other hand, OTS has the limitation of the 
required line-of-sight between the specific pattern of optical markers and the cameras. 
Near-IR light is also used in Microsoft Kinect (USA) to calculate depth images. That 
information is used to identify human shapes for skeletal tracking. Kinect version 1 
obtains that depth through the deformation of a known IR structured light pattern 
projected onto the scenario and acquired by an IR camera. In contrast, Kinect version 2 
depth is based on TOF of intensity-modulated near-IR light sent by a laser projector 
[63].  
Clinical applications of tracking systems include neurosurgery, orthopedic surgery, 
thoracoabdominal interventions and cardiovascular interventions [64]. In EBRT, 
tracking systems are used as follows:  
 To verify patient set-up (OTS with two passive markers and several laser 
spots) [65]. 
 To assess internal organ motion during the treatment of, for example, prostate 
cancer. Organ displacements are tracked by implanting wireless 
electromagnetic transponders that are excited by an electromagnetic array 
(Calypso system, Varian Medical Systems, USA). This solution also includes 
an OTS for tracking that array [66]. 
 To activate the radiation beam based on either organ motion obtained from 
Calypso system [67] or respiratory phase acquired with real-time position 
management (RPM, Varian Medical Systems). In this last solution, a specific 
object with several passive markers (from two up to six) is placed on the 
patient’s abdomen/thorax to obtain respiratory movements (OTS) [68, 69].  
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Finally, radioactive sources have been localised with an EMTS for real-time planning 
of IORT HDR brachytherapy [70]. 
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4 FEASIBILITY OF INTEGRATING A 
MULTI-CAMERA OPTICAL TRACKING 
SYSTEM IN IOERT SCENARIOS 
This chapter presents the specific study that assessed the feasibility of using a multi-
camera optical tracking system to obtain the applicator pose in IOERT scenarios. This 
research was related to the first specific objective of this thesis and was published in 
Physics in Medicine and Biology journal [71].  
4.1 INTRODUCTION 
As previously mentioned in section 3.7, the actual IOERT treatment administered to 
the patient is not completely characterised. One of the unknown variables is the 
applicator pose in relation to the patient’s anatomy that can be provided by a tracking 
system (section 3.9). An appropriate choice for IOERT scenarios (operating room [OR] 
with a multidisciplinary team) is an optical tracking system (OTS) due to its accuracy, 
wireless system, freedom of movements and working volume. To our knowledge, no 
studies have proposed this approach previous to the acceptance of our corresponding 
article [71]. Most OTSs make use of a relatively small number of cameras (two or 
three) [72, 73], thus reducing calibration requirements but limiting their practical use in 
complex clinical scenarios, where the required line-of-sight between the tracked objects 
and the cameras is easily obstructed. To overcome this limitation, we propose the use 
of a multi-camera OTS to ensure correct tracking of the applicator in a real IOERT 
setting, in which several actors and objects are moving around. Moreover, the 
applicator pose in relation to the patient’s anatomy can be integrated in the treatment 
planning system (TPS) in order to generate an accurate description of the IOERT 
scenario. 
This specific study had two objectives: first, to integrate a multi-camera OTS in the 
IOERT process, including the interaction with the IOERT planning system, and 
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second, to estimate the accuracy of the applicator pose in a phantom experiment that 
simulates three representative IOERT scenarios (breast, abdomen and rectum).  
4.2 MATERIALS AND METHODS 
This section describes the steps followed to obtain the position and orientation of the 
applicator in the treatment room with a multi-camera OTS (section System description) 
and the experiment designed to estimate the accuracy of the applicator pose (section 
Experiments). The tracking system was installed in the computed tomography (CT) 
simulation room, with a camera distribution similar to that used during a real treatment 
procedure. The gold standard for each IOERT scenario was generated by obtaining a 
CT study of the phantom, which simulated the patient’s bone structure, and the 
applicator. 
System description 
This section describes the multi-camera OTS and the tools required for its integration 
in the IOERT planning system. 
Optical tracking system 
The OTS OptiTrack (NaturalPoint Inc., USA) provides real-time position and 
orientation (six degrees of freedom) of rigid bodies with passive optical markers 
(section 3.9) (Figure 18). 
   
Figure 18. OTS: (a) rigid body with four spherical optical markers, (b) infrared (IR) camera,                 
(c) three-marker 400-mm OptiWand used to calibrate camera parameters. 
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Eight synchronised cameras (model OptiTrack FLEX:V100R2, NaturalPoint Inc., 
Figure 18) with a resolution of 640 x 480 pixels (VGA) and maximum frame rate of 
100 fps were placed around the scenario. This multi-camera approach covers a large 
working volume, thus making it well suited to the IOERT procedure.  
Tracking Tools software (NaturalPoint Inc.) processes information captured by the 
near-IR cameras in order to determine the pose of any rigid body in the real world 
(physical space). We developed a software application that receives the data sent by 
Tracking Tools software via the virtual-reality peripheral network protocol [74] and 
determines the pose of any object to which a specific rigid body is attached.  
Extrinsic camera parameters (physical position and orientation) and intrinsic camera 
parameters (focal length and lens distortion) were calibrated with a three-marker 
OptiWand (NaturalPoint Inc., Figure 18) and the three marker calibration algorithm 
(Tracking Tools software). The optical coordinate system is established by detecting a 
right scalene triangle on a flat surface with planar retro-reflective markers (area 
1 x 1 cm) in its three corners (area 16 x 21 cm) placed in the working volume. 
Pointer 
To obtain the spatial position of landmark points in the physical space, we designed a 
specific tool called a pointer, which was a pencil-shaped rigid body made of 
polyoxymethylene (POM) (Figure 19) with a sharp tip (diameter 1 mm). Six spherical 
optical markers (diameter 1.2 ± 0.2 cm, mean ± standard deviation [SD]) were 
asymmetrically arranged around this tool in such a way that the distances between all 
the markers were pairwise different (at least the diameter of the markers). These 
conditions are required by the OTS to unequivocally recognise this rigid body [75].  
The coordinates of the pointer tip in the physical space is obtained from equation (7), 
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 (7) 
where ܴ௣௢௜௡௧௘௥ is a 3x3 matrix which specifies the rotation from the initial orientation 
of the pointer to its current one. The offset from the geometric centre of the six optical 
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markers to the pointer tip is obtained with a manual calibration procedure involving 
continuous recording of tracking data (ܴ௣௢௜௡௧௘௥ and geometric centre) while the pointer 
is pivoted over its tip, which is inserted into a small hole. The offset and tip position are 
calculated by solving a system of equations which comes from re-writing equation (7) 
with the data collected [76].  
   
Figure 19. Optical tools: (a) pointer; (b) applicator, showing the trirectangular trihedron (vectors OA , 
OB and OC) used to fully characterise its pose. Point O is the bevel centre and point D represents the 
intersection of the bevel and the longer edge of the applicator. Vector OC is parallel to the longitudinal 
axis of the applicator, vector OB  (bevel axis) points to the longer edge of the applicator and is 
perpendicular to vector OC , and vector OA  is parallel to the cross product of vectors OB  and OC. In 
order to unequivocally recognise the orientation of the trirectangular trihedron, the magnitude of OB  is 
half of vector OC , and the magnitude of OA  is a third of vector OC . 
IOERT applicator  
Another rigid body with a configuration of four spherical optical markers (diameter    
1.1 cm, Hand Rigid Body, NaturalPoint Inc.) different from that of the pointer was 
attached to the IOERT applicator. The applicator pose in the physical space can be 
determined by applying an expression analogous to equation (7) to each point of the 
trirectangular trihedron OABC that fully characterises the applicator (Figure 19). It is 
also necessary to calibrate the applicator to obtain the offset from the geometric centre 
of the four optical markers to each point of the trirectangular trihedron (O, A, B and C). 
This calibration procedure is performed by using the pointer to locate the points O and 
D, and several small holes along the longitudinal axis of the applicator. Points A, B and 
C are determined by geometry. Each offset is then calculated by substituting the 
Advances in navigation and intraoperative imaging for IOERT 
61 
position of each point (O, A, B and C) and the current pose of the rigid body in an 
expression analogous to equation (7). 
Physical-to-image space registration 
To integrate the OTS in the IOERT planning system, it is necessary to establish spatial 
concordance between the patient pose in the IOERT treatment room (real world or 
physical space) and the preoperative CT image in the IOERT planning system (virtual 
world or image space). The applicator pose from the physical space is converted into 
the image space by applying a transformation matrix calculated with a landmark rigid 
registration algorithm based on singular value decomposition [77]. This procedure 
requires at least three fiducial markers attached to the patient around the area of interest 
and visible on the CT image (Figure 20). Coordinates in the physical space are 
obtained by placing the tip of the pointer over each landmark. Coordinates in the image 
space are obtained from the patient’s CT image with the aid of the orthogonal views 
and the volume rendering view of the IOERT planning system. 
 
Figure 20. Physical-to-image space registration (transformation matrix T): selection of f iducial points in 
both spaces. 
Experiments 
This section describes the experiment carried out in the CT simulator room to estimate 
the accuracy of the applicator pose calculations. Three representative IOERT scenarios 
(breast, abdomen and rectum) were simulated using a plastic skeleton to simulate the 
patient’s bone structure. The actual position and orientation of the applicator (gold 
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standard) for each scenario was obtained by performing a CT study of the phantom and 
the applicator together. Pointer accuracy was evaluated in a separate experiment.  
Optical tracking system set-up 
The cameras were statically attached to eight STOLMEN posts (Inter IKEA Systems 
B.V., Netherlands) around the table of a clinical CT system, following a U-shape 
configuration (Figure 21, area 6.84 m2, mean height 2.65 m and mean distance between 
adjacent cameras 1.26 m). This distribution simulated the position of the cameras in the 
IOERT treatment room. The experiment was carried out in the CT room in order to be 
able to generate the gold standard or actual applicator pose from the CT acquisition.  
 
Figure 21. OTS set-up for the experiment: IR cameras and three-marker OptiWand used to calibrate the 
cameras. 
IOERT applicator set-up 
The IOERT applicator used in this study was a polymethyl methacrylate (PMMA) tube 
measuring 7 cm in diameter with a bevel angle of 45º. Depending on the IOERT 
scenario, this device was placed on the region of interest (ROI) using an articulated 
arm that firmly attached the applicator to the CT scanner bed (Figure 22, Figure 23 and 
Figure 24). 
Metallic wires measuring 0.8 mm in diameter (SL-W8, The Suremark Company, USA) 
were attached to the longitudinal axis of the applicator and the contour of the bevel in 
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order to better determine its position and orientation from the CT image. The actual 
applicator pose in the image space was calculated by segmenting those metallic wires 
from the CT image by histogram thresholding. The metallic wire over the longitudinal 
axis was then adjusted to a line parallel to the vector OC (Figure 19) using a method 
based on principal component analysis [78], and an ellipse was adjusted to the 
coordinates of the metallic wire on the contour of the bevel using an algorithm based 
on least squares fit [79]. The quality of the fitting was assessed by calculating the root 
mean square (RMS) error between the coordinates of the segmented points and the 
closest points in the adjusted line and ellipse. Finally, points O, A, B and C (Figure 19) 
were determined by geometry. 
Phantom  
The plastic skeleton was placed on the table of the clinical CT system in the same 
position for all the IOERT scenarios, and close to the centre of the field of view (FOV) 
of the cameras. Six metallic nipple markers (diameter 1.5 mm, SL–15, The Suremark 
Company), which are routinely used to identify reference landmarks in CT scans, were 
placed on the skeleton around each ROI and used as fiducial points for the physical-to-
image space registration. The coordinates of these markers in the physical space were 
obtained by placing the pointer on the marker surface and in the image space by 
calculating the centroid of each one. Five spherical optical markers (diameter 1.1 cm, 
NaturalPoint Inc., same locations for the three IOERT scenarios) were also attached to 
the skeleton. The physical positions of these landmarks are not affected by pointer or 
operator error, as their centroids were obtained directly from the OTS. 
CT acquisition 
CT studies were acquired on a CT simulator (Toshiba Aquilion™ Large Bore scanner, 
Japan) with the acquisition parameters shown in Table 1. 
Evaluation 
- Pointer accuracy 
Pointer accuracy was estimated by placing the tip of the pointer in 17 different 
locations on a millimetre board (17 x 17 cm), located at the centre of the FOV of the 
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cameras and 1 m away from that centre. Pointer accuracy was assessed as the RMS 
error between the position of the pointer tip provided by the OTS and its actual position 
from the millimetre board.  
Table 1. CT acquisition parameters. 
 
Voltage 
(kVp) 
Exposure 
(mAs) 
Matrix size Voxel size (mm) 
Breast 120 21 ± 2a 512 x 512 x 363 1.5 x 1.5 x 2.0 
     
Abdomen 120 20 ±1a 512 x 512 x 448 1.6 x 1.6 x 2.0 
     
Rectum 120 30 512 x 512 x 462 1.3 x 1.3 x 2.0 
a Mean ± SD. 
 
- IOERT applicator pose accuracy 
The accuracy of the applicator pose was assessed by comparing the actual value 
obtained from the CT image with the virtual one provided by the OTS. The experiment 
was designed to evaluate two sources of error in the physical space: the pointer and the 
operator. For this purpose, two groups of measurements were taken: one where the 
operators manually selected the metallic markers and the other automatically tracking 
the optical markers. 
The details of the protocol used in each IOERT scenario (breast, abdomen and rectum) 
are as follows: 
1. The metallic markers were attached to the skeleton around the ROI (different 
distribution for each IOERT scenario) and the applicator was placed close to 
the phantom. 
2. The applicator and both metallic and optical markers were located in the 
physical space with the OTS. The position of the metallic markers was 
identified with the pointer three times by different operators in order to assess 
operator variability (reproducibility component). The applicator pose was also 
collected three times with the OTS (repeatability component). 
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3. A CT scan was acquired with a FOV covering the volume of the skeleton 
under study, ensuring that it included the metallic and optical markers, and the 
applicator. 
4. Step 2 was repeated after the CT scan in order to check the stability of the 
experiment. 
5. The centroids of both metallic and optical markers were calculated from the 
CT image, and their coordinates were matched to those obtained from the 
OTS, thus providing a rigid registration from the physical space to the image 
space. The fiducial registration error (FRE [80]) of each registration was 
calculated as the RMS distance between the transformed markers of the 
physical space and the markers of the image space (homologous markers after 
registration). 
6. The actual pose of the applicator related to the skeleton was estimated from 
the CT image (section IOERT applicator set-up). Its virtual pose was 
calculated by applying each registration (step 5) to the corresponding data of 
the applicator in the physical space (steps 2 and 4). 
7. The positioning error was estimated by the Euclidean distance between the 
coordinates of the bevel centre of the actual applicator and the virtual 
applicator. The orientation errors were assessed by the angle between the 
bevel axis OB (and the longitudinal axis OC) of the actual applicator and the 
virtual applicator.  
4.3 RESULTS 
The estimation of the extrinsic and intrinsic camera parameters yielded an overall 
OptiWand error of 0.173 ± 0.024 mm (mean ± SD, data provided by the Tracking 
Tools software). 
Pointer accuracy 
The RMS error of the pointer tip was 1.7 mm (SD of the error 0.5 mm) at the centre of 
the FOV of the cameras and 2.2 mm (SD of the error 0.3 mm) at a distance of 1 m. 
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This error was close to the diameter of the tip (1 mm) and was significantly higher 1 m 
away from the centre of the FOV (p < 10-3, Student’s t-test, paired sample, N=17). 
IOERT applicator pose accuracy 
As no statistically significant differences were detected in the results depending on 
whether the position of the markers was obtained before or after the CT scan, both data 
sets were pooled. Table 2 shows the FRE of the rigid registration between the 
transformed markers of the physical space and the markers of the image space. The 
metallic wires of the applicator (longitudinal axis and contour of the bevel) were 
adjusted yielding an RMS error of 1.4 ± 0.3 mm (calculated as described in section 
IOERT applicator set-up [section 4.2]).  
Table 3 shows the pose errors between the actual applicator and the virtual applicator. 
The mean errors were 1.8 mm for the bevel centre, 1.6º for the bevel axis and 0.7º for 
the longitudinal axis. Figure 22, Figure 23 and Figure 24 illustrate the applicator pose 
in the physical space for the breast, abdomen and rectum IOERT scenarios 
respectively, and also the pose of the actual applicator and the virtual applicator in the 
IOERT planning system. Most of the variance of the applicator error (without factor 
scenario) can be attributed to the inter-observer variability of the marker locations in 
the physical space (reproducibility component) while the repeatability component 
related to the OTS was negligible (data not shown). As an example, the variance 
components analysis of the bevel axis error yielded an estimated variance of the 
repeatability component of 3.5 x 10-6 mm2 for the abdomen scenario and using the data 
collected after the CT scan. 
Table 2. FREa between homologous markers after registration. 
 FRE (mm) 
Metallic markersb 1.3 ± 0.4* 
Optical markersb 0.8 ± 0.2* 
a Mean ± SD. 
b Average of breast, abdomen and rectum scenarios. 
*p < 0.001 (Student’s t-test, paired sample).  
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Table 3. Positioning and orientation errorsa between homologous markers after registration.  
 Bevel centre (mm) Bevel axis (º) Longitudinal axis (º) 
IOERT scenariosb 1.8 ± 0.5 1.6 ± 0.5 0.7 ± 0.3 
Breastc 1.4 ± 0.3 2.0 ± 0.3 0.4 ± 0.2 
Abdomenc 2.0 ± 0.5 1.4 ± 0.1 1.0 ± 0.1 
Rectumc 1.9 ± 0.4 1.1 ± 0.2 0.9 ± 0.2 
Metallic markersd  1.9 ± 0.5* 1.6 ± 0.5 0.7 ± 0.3 
Optical markersd  1.4 ± 0.3* 1.5 ± 0.3 0.6 ± 0.2 
a Mean ± SD. 
b Average of all data.  
c Average of metallic and optical markers data.  
d Average of breast, abdomen and rectum scenarios. 
*p < 0.03 (Student’s t-test, paired sample). 
 
 
 
  
Figure 22. Breast IOERT scenario: (a) applicator and skeleton (physical space), (b) actual applicator 
and virtual applicator on the volume rendering of the skeleton (image space). 
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Figure 23. Abdomen IOERT scenario: (a) applicator and skeleton (physical space), (b) actual applicator 
and virtual applicator on the volume rendering of the skeleton (image space). 
 
  
Figure 24. Rectum IOERT scenario: (a) applicator and skeleton (physical space), (b) actual applicator 
and virtual applicator on the volume rendering of the skeleton (image space). 
4.4 DISCUSSION 
In this study, a multi-camera OTS was integrated for the first time in the IOERT 
procedure, specifically into the radiance TPS, in order to further evaluate the actual 
dose distribution in the patient. We assessed the accuracy of the IOERT applicator pose 
in an end-to-end experiment resembling real treatment scenarios that were selected 
according to the most common intraoperative radiation therapy (IORT) sites (breast 
31.8%, abdomen 29% and rectum 19.6% [18], this tendency has recently been 
confirmed by European expert institutions [22]) (Figure 25). Our results included 
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several sources of error involved in the real process: calibration of the optical tools, 
intrinsic optical system limitations and point-to-point registration with user interaction. 
The IOERT multidisciplinary staff and the use of several surgical support devices 
might easily obstruct the line-of-sight between tracked objects and the OTS if few 
cameras are used, thus seriously degrading tracker performance. Our solution makes 
use of more cameras to overcome these occlusion problems, as they are arranged 
around the working volume. In [81], the authors reported the use of the Vicon MX 
visual-tracking system (Vicon Motion Systems, USA) with five near-IR cameras on the 
walls of a single photon emission computed tomography (SPECT) room. This study 
showed sub-millimetric accuracy for motion tracking during cardiac SPECT imaging, 
with every optical marker on the patient localised at least 84% of the time, and 
emphasised the flexibility of camera placement to improve marker viewing. 
 
Figure 25. Frequency of IORT sites in Europe (ISIORT-Europe 2004 survey). GI (gastrointestinal). 
Source [18]. 
As the pointer is a key tool in this experiment, we first estimated its accuracy (between 
1.7 and 2.2 mm). In [72], the authors reported that the accuracy of the location of 
individual optical markers with OTSs (typically 0.25 mm) is better than when using 
tool tips (up to 2 mm), in accordance with our results. Although the use of a pointer to 
manually select reference positions could seem suboptimal, it is essential in practice for 
registration and navigation in certain scenarios, such as the tumour bed, where placing 
a marker might not be feasible. 
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Regarding the articulated arm that attached the applicator to the CT scanner bed, we 
demonstrated that the applicator was held steady throughout the process, including the 
CT acquisition, since errors before and after the acquisition were statistically 
equivalent.  
The physical-to-image space registration was performed with an FRE of 1.3 ± 0.4 mm. 
This result includes inter-operator variability. FRE was also calculated for registrations 
with optical markers, which are not affected by pointer error, and proved to be 
0.8 ± 0.2 mm. This latter error was slightly better, although both results are within the 
slice thickness of the CT images. Both solutions could be used in the IOERT scenarios 
we describe, although the pointer and the metallic markers (or other anatomical 
landmarks) are a more flexible solution, given the limitations in the radio-surgical 
treatment theatre. The physical-to-image space registration for this solution was 
obtained using six metallic markers. In external beam radiation therapy (EBRT), the 
patient is commonly positioned by aligning three skin markers (minimum number to 
establish spatial concordance) with in-room lasers [82]. If one of these three markers is 
mislocated, the registration becomes biased. In our case, we would recommend the use 
of a minimum number of four markers. A large FRE in any marker may indicate a local 
displacement in that area, and in that case the best three markers could be selected for 
the alignment. Another source of error is the uncertainty in the localization of the 
marker centroids in the CT image. However, decreasing voxel size might not 
significantly improve the results as the registration error is also affected by the pointer 
accuracy, and consequently the increase in radiation dose for the patient would not be 
justified. 
The integration of the OTS in the IOERT planning system is illustrated in the figures 
that show the fusion of the actual applicator and the virtual applicator. Our accuracy 
results for the applicator pose could be evaluated using the recommendations from 
Task Group 147 (TG–147, commissioned by the Therapy Committee and the Quality 
Assurance and Outcomes Improvement Subcommittee of the AAPM to study the 
localization accuracy with non-radiographic methods such as IR systems in EBRT 
[73]). According to TG–147, when the phantom used to perform the daily quality 
assurance is positioned at the treatment isocentre based on the room lasers, the non-
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radiographic system should localise the phantom within 2 mm of that location [73]. In 
our experiment, the accuracy of the applicator pose was below 2 mm in position (mean 
error of the bevel centre) and 2º in orientation (mean error of the bevel axis and the 
longitudinal axis), which corresponds to 1.8 mm (the arc length along the bevel of the 
7-cm–diameter applicator [83]). These measurements are small when compared to the 
diameter of the IOERT applicator (7 cm), and within the acceptable range proposed in 
the TG–147 recommendation. The fact that the positioning error of the applicator is 
slightly higher with the metallic markers than with the optical ones suggests that this 
discrepancy could be due to pointer error. This difference (0.5 mm on average) is 
similar to the FRE between both types of markers. However, the coordinates of the 
metallic and optical markers in the physical space were obtained following a different 
methodology, namely, by placing the pointer on the surface of each metallic marker 
and by assessing the centroid of each optical marker. Therefore, the discrepancy may 
also be attributed to the procedure of the marker location in the physical space, since 
the radius of the metallic markers (0.75 mm) is close to the difference in the 
positioning error of the applicator. 
Our results represent a major step towards the use of this approach in IOERT. 
However, some issues still need to be addressed. Although the experiment described 
makes use of one post for every camera, the final set-up in the IOERT treatment room 
could take advantage of a tubular structure hanging from the ceiling to which the 
cameras could be easily attached in positions similar to those evaluated. Moreover, the 
rotation of the cameras would be adjusted in order to better cover the FOV of the 
IOERT treatment. The clinical installation would be checked by means of repeating the 
experiments described in this work. The whole setting (the phantom and the applicator) 
would be carefully transferred from the IOERT treatment room to the CT simulator 
room by means of a CT compatible transport bed [84] in order to acquire the gold 
standard. Accuracy of the applicator pose would be similar in the IOERT room, except 
for the occlusion problems caused by, for instance, operating theatre personnel and 
anaesthetic and laparoscopic instruments. This limitation has been partially evaluated 
because our results were obtained in a scenario in which the operator blocked the view 
of some cameras while using the pointer. Degradation of tracker performance in the 
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IOERT treatment room is likely to be low, since the applicator is correctly tracked if its 
rigid body is well designed and at least three optical markers are seen by at least two 
out of the eight cameras in the OTS (stereo vision). In fact, the cameras are placed 
surrounding the scenario in order to reduce occlusions. Nevertheless, a figure of merit 
of the tracking process would be useful for the interactive assessment of the data 
collected by the multi-camera OTS. SD of the collected position, the number of optical 
markers of the pointer or the applicator actually seen and the number of cameras 
occluded would be taken into account in this figure of merit. On the other hand, as the 
skeleton phantom represents an idealised and simplified patient, the accuracy of the 
applicator pose achieved in our experiment may be considered to be a lower limit. The 
real treatment procedure will introduce several factors, such as retraction of structures, 
removal of affected tissues, internal organ displacement and placement of protections, 
which require further study. In addition, these issues could modify the geometry of the 
surgical site and increase the difference with the preoperative image used to plan the 
radiation treatment. Conventional preoperative CT imaging of the patient in a position 
resembling the surgical operation could decrease these dissimilarities. A better solution 
would be to use intraoperative imaging, which offers updated anatomical information 
[85]. To this end, a mobile C-arm that provides cone-beam CT (CBCT) imaging 
capability, but with a limited FOV, has been proposed [86, 87]. Such a solution would 
enable IOERT dosimetry planning to be more easily adapted to a real scenario after 
physical-to-image space registration. Regarding the protections, the tip of a sterilised 
pointer could be used to delimit the contour of the shielding plates in the surgical site in 
order to obtain its position in relation to the applicator pose, provided the handle of the 
pointer where the optical markers are placed is visible. 
4.5 CONCLUSIONS 
We evaluated the accuracy of IOERT applicator pose with a multi-camera OTS by 
means of a phantom study. The results of this experiment, which was designed to 
simulate real treatment scenarios, reveal positioning and orientation errors below         
2 mm. This lower limit encourages us to evaluate the feasibility of this approach in 
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further clinical studies. The virtual applicator integrated in an IOERT planning system 
allows the radiation oncologist to better estimate the real IOERT dose delivered to the 
patient during the procedure and, consequently, will benefit the radiotherapy response 
assessment. 
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5 COMPARISON OF PREOPERATIVE AND 
INTRAOPERATIVE CT IMAGES FOR IOERT 
DOSE ESTIMATION 
This chapter introduces the specific study that assessed the feasibility of acquiring 
intraoperative computed tomography images in real IOERT scenarios. These 
intraoperative studies were used to evaluate the improvement achieved in the dose 
distribution estimation when compared to that obtained from preoperative CT images, 
identifying the dominant factor in that estimation. This research was related to the 
second objective of this thesis. Preliminary results of this study were presented in the 
American Society for Radiation Oncology (ASTRO) conference [85]. 
5.1 INTRODUCTION 
Patient position, surgical access, tumour resection and IOERT treatment set-up in the 
actual IOERT field can differ from those simulated in the treatment planning system 
(TPS). Intraoperative images of the actual scenario during the treatment would be 
useful not only for intraoperative planning but also for registering and evaluating the 
treatment administered to the patient. Actual IOERT dose distributions would also 
enable calculating dose accumulation when external beam radiation therapy (EBRT) is 
applied after an IOERT boost. 
As previously mentioned in section 3.6, surface irregularities can significantly affect 
the IOERT dose distribution. In [12], the authors simulated some characteristic pelvic 
IOERT scenarios (rectal cancer) with solid water slabs and radiotherapy bolus and 
showed that curved irradiation surfaces caused dose distributions to be curved and 
deeper than those with flat surfaces. Moreover, a cavity smaller than the applicator 
produced hot spots close to the surface followed by a fast dose reduction. In a previous 
work [85], our group evaluated the difference between the 3D dose distributions 
obtained with preoperative computed tomography (CT) images and their corresponding 
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intraoperative CT images acquired during the IOERT. An average dose difference of 
5% was found after applying some preprocessing in the preoperative images, namely 
removal of the tumour and its surrounding tissues as expected during surgery and then 
deformable registration to the intraoperative studies. The average dose difference 
increased to 10% when using rigid alignment instead of deformable registration. This 
evaluation was carried out just in two clinical cases (Ewing and undifferentiated 
sarcoma) and did not take account of distance-to-agreement (DTA) concept as does the 
gamma index [38], which is the mainstay of dose distribution comparisons in medical 
physics (section 3.5).  
In this specific study, we aimed to assess the feasibility of acquiring intraoperative CT 
images in real IOERT scenarios extending the number of cases and IOERT sites 
presented in [85]. We also compared the 3D dose distributions estimated with 
intraoperative CT images (gold standard) to those obtained under the assumption of 
having just water at the end of the applicator (conventional assumption), tissue 
heterogeneities (data from their corresponding preoperative CT images) or adding an 
air gap at the end of the applicator. The comparisons were done in terms of gamma 
criteria. With this approach, we assessed if dose estimation on preoperative images is a 
good predictor of the intraoperative case, identifying the dominant factor in that 
estimation. 
5.2 MATERIALS AND METHODS 
In this section, we describe the IOERT cases evaluated in this study, the protocol used 
to acquire the preoperative and intraoperative CT images, the processing done in these 
images and the details of the dose distribution estimation with the comparisons carried 
out. 
IOERT cases  
Six patients undergoing IOERT were enrolled for this study. Informed consent was 
obtained from all patients. The diagnosis of each patient and the parameters of their 
radiotherapy treatment are detailed in Table 4. The study included several IOERT sites. 
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In both breast cancer cases, a shielding disc was used to protect intrathoracic organs 
during irradiation. These shielding discs were made of lead with a diameter of 6 cm 
(1 cm larger than the applicator diameter) and thickness 3 mm. Surgical retractors 
made of stainless steel were included in the retroperitoneal case. 
Table 4. IOERT parameters. 
 Applicator 
diameter (cm) 
Bevel 
angle 
Energy 
(MeV) 
90% isodose 
(Gy) 
Patient 1 
(Ewing sarcoma) 
8 15º 6 10 
Patient 2 
(Rhabdomyosarcoma)
12 30º 8 12.5 
Patient 3 
(Breast cancer, right) 
5 30º 6 10 
Patient 4 
(Breast cancer, left) 
5 0º 6 10 
Patient 5 
(Retroperitoneal 
sarcoma) 
10 30º 8 12.5 
Patient 6 
(Chondrosarcoma) 
7 30º 8 12.5 
     
Protocol description 
The conventional IOERT protocol included patient’s transfer from the operating room 
(OR) to the LINAC room (bunker) for irradiation. This transfer was necessary since a 
dedicated mobile LINAC to be used inside the OR was not available. In this study, 
preoperative CT images for those six patients were acquired on an Aquilion™ Large 
Bore CT simulator (Toshiba, Japan; Patient 1, 2 and 6), on an MX8000 CT (Philips, 
The Netherlands, Patient 3 and 4) and on a Brilliance 16 CT (Philips, Patient 5). The 
IOERT protocol was modified as follows in order to incorporate the acquisition of an 
intraoperative CT image of the actual IOERT scenario:  
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1. The patient lay on a rigid radiotransparent subtable that was placed over the 
operating table during the surgery. The use of this subtable did not allow 
removing or individually moving the different segments of the surgical table.  
2. After tumour resection, the IOERT applicator was placed on the tumour bed 
and was firmly attached to that radiotransparent subtable with an articulated 
arm.  
3. The patient was covered to maintain asepsis of the surgical field during the 
transfer to the CT simulator room and the treatment room. A subtable 
stretcher, similar to that presented in [84], allowed carrying the subtable from 
the operating table to the CT/LINAC table. The radiotransparent subtable and 
the subtable stretcher were manufactured for this study. 
4. An intraoperative CT image of the whole setting (patient and applicator) was 
acquired on a Toshiba Aquilion™ Large Bore CT simulator.  
After these steps, the conventional protocol was followed: the patient was transferred 
to the LINAC room for tumour bed irradiation and then to the OR for surgical closure.  
All the involved facilities (OR, CT simulator and LINAC treatment unit) were located 
in the Radiation Oncology Service at Hospital General Universitario Gregorio Marañón 
(Madrid, Spain). Patients were under general anaesthesia during the whole procedure. 
No decisions regarding IOERT parameters (beam energy and prescribed dose) were 
taken based on this intraoperative data. Table 5 includes the CT acquisition parameters 
of the preoperative images and intraoperative images, and the temporal interval 
between both image studies. 
Image processing 
Image registration 
Each preoperative image was rigidly registered to its corresponding intraoperative 
image. This enabled us to calculate the dose distribution in both preoperative and 
intraoperative images under the assumption of having the same applicator pose in 
relation to the patient’s anatomy. This step focused on aligning bones to facilitate the 
registration process and was done after the following preprocessing. Firstly, all 
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preoperative and intraoperative images were resampled to 1.5-mm isotropic voxel size 
to facilitate further comparisons. After that, all images were translated to place the 
region of interest (ROI), namely the tissues close to the applicator bevel, in the image 
centre and were also cropped to remove tissues that could hinder the registration. Then, 
masks were obtaining by segmenting the bones close to the applicator bevels using 
region growing method and manual frontiers. Finally, segmented images were created 
by using those masks so that the background was set to zero and bones were set to their 
original CT values. Each segmented preoperative image was rigidly aligned with its 
corresponding segmented intraoperative image using normalised mutual information as 
cost function. Each registration parameters (3 translations and 3 rotations) were then 
applied to the corresponding translated and cropped preoperative image. 
Table 5. CT acquisition parameters. 
 
Days 
between 
images 
Voltage 
(kVp) 
Exposure 
(mAs) 
Matrix 
size 
Voxel size 
(mm) 
Patient 1 
(Ewing sarcoma) 
6 120 
35 ± 7a,b 
125c 
512 x 512 x 117b 
512 x 512 x 201c 
1.3 x 1.3 x 5.0b 
1.3 x 1.3 x 2.0c 
      
Patient 2 
(Rhabdomyosarcoma) 
1 120 125 
512 x 512 x 238b 
512 x 512 x 227c 
1.1 x 1.1 x 2.0b 
1.6 x 1.6 x 2.0c 
      
Patient 3 
(Breast cancer, right) 
17 120 
100b 
127 ± 66a,c 
512 x 512 x 221b 
512 x 512 x 129c 
0.6 x 0.6 x 1.6b 
1.3 x 1.3 x 3.0c 
      
Patient 4 
(Breast cancer, left) 
9 120 
100b 
114 ± 27a,c 
512 x 512 x 238b 
512 x 512 x 58c 
0.7 x 0.7 x 1.6b 
1.1 x 1.1 x 5.0c 
      
Patient 5 
(Retroperitoneal 
sarcoma) 
1 120 
196 ± 22a,b 
217 ± 7a,c 
512 x 512 x 630b 
512 x 512 x 218c 
0.7 x 0.7 x 1.0b 
1.4 x 1.4 x 2.0c 
      
Patient 6 
(Chondrosarcoma) 
0 120 
132 ± 62a,b 
144 ± 54a,c 
512 x 512 x 435b 
512 x 512 x 193c 
1.2 x 1.2 x 2.0b 
0.9 x 0.9 x 2.0c 
a Mean ± standard deviation (SD). 
b Preoperative CT image. 
c Intraoperative CT image. 
 
 
 80 
Air gap segmentation 
From the point of view of the electron beam (beam’s-eye view), a difference between 
preoperative images and intraoperative images is the air between the end of the 
applicator and the tumour bed. Another preoperative image was created following the 
subsequent steps to take account of this aspect in the comparison of IOERT dose 
distributions. Firstly, the air gap between the end of the applicator and the tumour bed 
was segmented in each transformed intraoperative CT image (the one translated and 
cropped) using region growing method (maximum limit –500 HU) and manual 
frontiers. This segmentation was restricted to the bevel and along the geometric axis of 
the applicator since excision cavities could be larger. Then, each inverted mask was 
applied to its corresponding registered preoperative image so that the background (air) 
was set to the CT value of air (–1000 HU) and tissues were set to their original CT 
values.  
Applicator pose identification 
The transformed intraoperative CT images enabled us to estimate the applicator pose 
(position of the bevel centre and rotation of the applicator relative to its initial 
orientation in the TPS) as their field of view (FOV) covered the irradiated tissues and 
the applicator. The drawback is that CT values of the applicator are similar to those of 
soft tissues so the following semiautomatic method was used to estimate the applicator 
pose in each transformed intraoperative image. Firstly, some specific regions of the 
applicator were segmented using region growing method and manual frontiers. These 
masks were used to calculate the two angles that aligned the geometric axis of the 
applicator with the axial axis of each transformed intraoperative CT image. This is the 
initial orientation of the applicator in the TPS except for the rotation around the 
geometric axis of the applicator. After that alignment, a short cylinder of the applicator 
was segmented using region growing method. The coordinates X and Y of the bevel 
centre were estimated by averaging the centres of the circumferences adjusted to every 
axial slice of that mask. Next, the end of the shorter edge (applicator) was manually 
located in the corresponding axial slice of each transformed intraoperative CT image 
and this information was used to calculate the coordinate Z of the bevel centre. After 
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that, a virtual applicator with the diameter and bevel angle specific to that IOERT case 
and with the initial orientation in the TPS was superimposed on each transformed 
intraoperative image. Its position was set according to the bevel centre estimated. Then, 
this virtual applicator was manually rotated around its geometric axis until matching 
the one depicted in each transformed intraoperative image. This step provided the third 
rotation of the applicator. Finally, the coordinates of the bevel centre and the three 
rotations obtained in the whole process were accordingly transformed to build the 
matrix that defined the pose of the virtual applicator in the TPS related to the initial 
one. 
IOERT dose distributions 
IOERT cases were simulated with radiance TPS (GMV, Spain) [3] using the registered 
preoperative images (without air gap [preCT] and with air gap [preCTair]) and the 
transformed intraoperative images of each patient (intraCT).  
The relationship between HU and density was entered into the IOERT TPS before 
calculating any dose distribution. This calibration curve was obtained by using a CT of 
an electron density phantom (model 062, CIRS Inc., USA) acquired in the same 
scanner as in the case of the preoperative/intraoperative images. The stoichiometric 
calibration [55, 56] was done to take account of that the electron density phantom is 
made of tissue-equivalent materials that represent the densities of tissues but do not 
usually replicate their chemical composition (section 3.8 and section Conversion of the 
CT number to physical density [section 6.2]). 
The IOERT parameters (applicator diameter, bevel angle and energy) shown in Table 4 
were introduced in the TPS. The energy of the sixth IOERT case (8 MeV) was replaced 
with 9 MeV as the TPS did not include this energy for the applicator used in that 
treatment (diameter 7 cm and bevel angle 30º). In each image, a virtual applicator was 
placed in the same pose as depicted in the intraCT by using the transformation matrix 
obtained in section Applicator pose identification. The tissue inside the applicator was 
set to the CT value of air automatically by the TPS. Dose distributions were calculated 
with the registered preoperative images (preCT and preCTair) and the transformed 
intraoperative images (intraCT) of each patient using pencil beam algorithm (resolution 
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1.5 mm) [49, 88] and Monte Carlo algorithm (error tolerance 1%, resolution 1.5 mm) 
[50] specifically adapted for IOERT. Another dose distribution was also estimated 
from each registered preoperative image (without air data) by selecting Water option 
(preCTwater). This choice allows calculating the dose without taking into account tissue 
heterogeneities, just assuming water at the end of the applicator. Doses were not scaled 
to a normalised value (100% corresponded to the maximum dose along the clinical axis 
when using a water phantom, the same applicator diameter, bevel 0º, the same energy 
and a specific source-to-surface distance [measurements for modelling treatment unit]).  
Dose distributions calculated from preoperative images (preCTwater, preCT and 
preCTair) were compared with that estimated with their corresponding intraoperative 
image (intraCT) in terms of the gamma index (section 3.5). Since no values have been 
established for IOERT, we used a 3D gamma criteria of 3%/3 mm and 5%/2 mm for 
dose values greater than either 10% or 70% (to focus on high dose regions). The 
acceptance criteria 5%/2 mm includes a tighter distance tolerance that could be more 
appropriate for the characteristic dose distribution of electron beams (mainly dose 
decreases below 10% after only a few centimetres). The dose distributions obtained 
from the intraoperative images were considered the gold standard as these images 
represented the patient anatomy just before the irradiation. A mask obtained by 
segmenting the tissue in each intraCT with region growing method (minimum limit                
–700 HU for Patient 1 and –625 HU for Patient 2 and Patient 6) and manual frontiers 
was applied in the 3D gamma analyses to remove dose differences of regions not 
belonging to each patient. 
5.3 RESULTS 
The six patients underwent IOERT following the described protocol and there were no 
complications in the whole procedure related to the transport step using the subtable 
and its stretcher or the acquisition of intraoperative CT images (for example, 
anaesthetic stability or other clinical relevant observations).  
Dose distributions were not calculated in three cases (Patient 3, 4 and 5) since there 
were metal artefacts (severe streaking) that substantially modified the HU of the 
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intraoperative images. These artefacts were due to metallic objects such as the 
shielding discs in the breast cancer cases (Figure 26 and Figure 27) and surgical 
retractors in the retroperitoneal case (Figure 28). In the intraoperative images of both 
breast cancer cases, there were dark streaks along the radial axis of the shielding discs 
and bright streaks along its perpendicular axis. For instance, the bright streak in                 
Figure 27 was about 36 mm, one order of magnitude larger than the thickness of the 
shielding disc. The contralateral breast allowed checking the proper range of CT values 
corresponding to the involved tissues. In the case of the third patient, the applicator was 
not firmly attached and it moved during the transfer to the CT room. Its intraoperative 
image showed that the shielding disc was not aligned with the applicator (Figure 26). 
The applicator pose was corrected before irradiation in that IOERT case. 
 
Figure 26. Patient 3’s intraoperative image (breast cancer, right). 
 
Figure 27. Patient 4’s intraoperative image (breast cancer, left). 
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Figure 29, Figure 30 and Figure 31 illustrate the alignment between the preoperative 
CT images and the intraoperative CT images. The registration was focused on aligning 
the bones close to the applicator bevel and this step was checked by visual inspection. 
The other bones and some soft tissue did not perfectly match due to the rigid 
registration. Figure 32 shows the alignment between the virtual applicator and that 
shown in each intraoperative image. The pose of the virtual applicator was obtained 
following the semiautomatic method explained in section Applicator pose 
identification (section 5.2). The maximum distances from the end of the applicator to 
the tumour bed were 30.5 mm (Patient 6), 14.5 mm (Patient 1) and 8.5 mm (Patient 2), 
(Figure 33). 
 
 
 
Figure 28. Patient 5’s intraoperative image (retroperitoneal sarcoma). 
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Figure 29. Registered images (Patient 1, Ewing sarcoma). Preoperative image (colour) superimposed 
on its intraoperative image (greyscale). PreCT (top) and preCTair  (bottom). From left to right, sagittal 
view, coronal view and axial view. 
 
Figure 30. Registered images (Patient 2, rhabdomyosarcoma). Preoperative image (colour) 
superimposed on its intraoperative image (greyscale). PreCT (top) and preCTair  (bottom). From left to 
right, sagittal view, coronal view and axial view. 
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Figure 31. Registered images (Patient 6, chondrosarcoma). Preoperative image (colour) superimposed 
on its intraoperative image (greyscale). PreCT (top) and preCTair  (bottom). From left to right, sagittal 
view, coronal view and axial view. 
 
 
 
Figure 32. Virtual applicator (greyscale) superimposed on the volume rendering of each intraoperative 
CT image (colour). From left to right, Patient 1 (Ewing sarcoma), Patient 2 (rhabdomyosarcoma) and 
Patient 6 (chondrosarcoma). 
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Figure 33. Maximum distance from the applicator bevel to the tumour bed. From left to right, Patient 1 
(Ewing sarcoma, 14.5 mm), Patient 2 (rhabdomyosarcoma, 8.5 mm) and Patient 6                      
(chondrosarcoma, 30.5 mm). 
 
For each IOERT case, the dose distributions from its intraoperative image and 
preoperative images (preCTwater, preCT and preCTair) can be compared in Figure 34 
(Patient 1), Figure 35 (Patient 2) and Figure 36 (Patient 6). The dose distribution from 
preCTair closely follows that from the intraCT image, more than using preCTwater or 
preCT. The percentage of voxels fulfilling the gamma criteria is detailed in Table 6, 
Table 7 and Table 8. The values are less restrictive when calculating the dose 
distribution with pencil beam algorithm than with Monte Carlo algorithm in most 
cases. Dose distributions using preCTair showed values above 95% in all cases except 
in three comparisons (gamma pass rates of 94.4%, 94.6% and 93.7% respectively in 
those specific cases), yielding better results than when using preCTwater (just two out of 
24 comparisons were above 95%) or preCT (just four out of 24 comparisons were 
above 95%). 
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Figure 34. Dose distr ibutions estimated with Monte Carlo algorithm (Patient 1, Ewing sarcoma). From 
top to bottom, the dose distribution corresponding to intraCT, preCTwater , preCT and preCTair . From left 
to right, sagittal view, coronal view, axial view and dose scale. R (right) and L (left). 
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Figure 35. Dose distributions estimated with Monte Carlo algorithm (Patient 2, rhabdomyosarcoma). 
From top to bottom, the dose distribution corresponding to intraCT, preCTwater , preCT and preCTair . 
From left to right, sagittal view, coronal view, axial view and dose scale. R (right) and L (left). 
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Figure 36. Dose distributions estimated with Monte Carlo algorithm (Patient 6, chondrosarcoma). From 
top to bottom, the dose distribution corresponding to intraCT, preCTwater , preCT and preCTair . From left 
to right, sagittal view, coronal view, axial view and dose scale. R (right) and L (left).  
 
 
 
 
 
Advances in navigation and intraoperative imaging for IOERT 
91 
 
Table 6. Percentage of voxels fulfilling the gamma criteria for the case of preCTwater.a 
 3%/3 mm 5%/2 mm 
 Dose > 10% Dose > 70% Dose > 10% Dose > 70% 
 PB MC PB MC PB MC PB MC 
Patient 1 
(Ewing sarcoma) 
87.1 82.3 86.9 80.1 85.2 80.2 85.5 78.9 
Patient 2 
(Rhabdomyosarcoma) 
93.6 90.0 95.3 92.0 92.9 89.8 95.2 92.9 
Patient 6 
(Chondrosarcoma) 
60.4 52.6 56.1 41.5 56.3 48.3 50.7 38.9 
a Percentages of voxels fulfilling the gamma criteria higher than 95% are highlighted in bold.  
  PB (pencil beam) and MC (Monte Carlo). 
 
Table 7. Percentage of voxels fulfilling the gamma criteria for the case of preCT.a 
 3%/3 mm 5%/2 mm 
 Dose > 10% Dose > 70% Dose > 10% Dose > 70% 
 PB MC PB MC PB MC PB MC 
Patient 1 
(Ewing sarcoma) 
86.9 82.2 86.9 80.3 84.7 80.0 85.4 79.6 
Patient 2 
(Rhabdomyosarcoma) 
95.9 92.2 95.4 92.1 95.9 92.7 95.4 93.0 
Patient 6 
(Chondrosarcoma) 
60.7 53.6 56.8 41.7 56.7 49.8 51.5 39.0 
a Percentages of voxels fulfilling the gamma criteria higher than 95% are highlighted in bold. 
  PB (pencil beam) and MC (Monte Carlo). 
 
Table 8. Percentage of voxels fulfilling the gamma criteria for the case of preCTair.a 
 3%/3 mm 5%/2 mm 
 Dose > 10% Dose > 70% Dose > 10% Dose > 70% 
 PB MC PB MC PB MC PB MC 
Patient 1 
(Ewing sarcoma) 
99.9 99.5 99.9 99.8 100.0 99.6 100.0 99.9 
Patient 2 
(Rhabdomyosarcoma) 
99.9 99.4 99.8 99.1 99.9 99.7 100.0 99.7 
Patient 6 
(Chondrosarcoma) 
95.4 94.4 97.1 97.4 94.6 93.7 96.2 96.2 
a Percentages of voxels fulfilling the gamma criteria higher than 95% are highlighted in bold. 
  PB (pencil beam) and MC (Monte Carlo).
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5.4 DISCUSSION 
This is the first study to compare 3D dose distributions estimated with intraoperative 
CT images of patients during IOERT (gold standard) to those obtained under the 
assumption of having just water at the end of the applicator (conventional assumption), 
tissue heterogeneities (data from their corresponding preoperative CT images) or 
adding an air gap at the end of the applicator. The comparisons were done in terms of 
gamma criteria. In our research, we assessed the feasibility of acquiring intraoperative 
CT images in real IOERT scenarios extending the number of cases and IOERT sites 
presented in [85]. There were no complications by applying the modified protocol 
mainly due to the trained multidisciplinary team (namely surgeons, radiation 
oncologists, anaesthesiologists, nurses and radiotherapy technicians) used to carry out 
the conventional protocol that involved transferring the anaesthetised patient from the 
OR to the LINAC room for patient irradiation. 
Dose distributions were not calculated in three cases since there were metal artefacts 
that substantially modified the HU of the intraoperative images due to the shielding 
discs in the two breast cancer cases and the retractors in the retroperitoneal sarcoma. A 
two-layered disc such as the one presented in [89] would decrease, but not remove, the 
metal artefacts in intraoperative images, thanks to the lower attenuation coefficient of 
copper compared to lead. In the case of retractors, a possible approach would be to 
remove these devices just before the CT acquisition or to use a non-metallic version of 
them, although this is not widely available for clinical use. The solution presented in 
[90], an Army/Navy retractor 3D printed with thermoplastic (polylactic acid, PLA) 
could be an option. Other alternative to be evaluated, also applicable to the breast 
cancer cases, would be replacing the incorrect CT values with the corresponding ones 
from the registered preoperative image or even with the mean CT values of certain 
regions from the contralateral side. 
The dose distributions estimated with the intraoperative images (gold standard) showed 
differences with respect to those corresponding to water assumption (Table 6). The 
isodose curves calculated with the intraoperative images were shifted downwards 
compared to those from preCTwater due to the presence of the air gap. The longer the 
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maximum distance from the applicator bevel to the tumour bed (air gap), the larger the 
difference in terms of gamma criteria between the gold standard and the dose 
distribution estimated under the water assumption. Surface irregularities influenced the 
dose distributions, as displayed in Figure 34 and Figure 36, an expected result in 
accordance with previous studies [10, 12]. Scatter produced by sharp irregularities in 
the irradiated surface produce hot or cold spots in the underlying tissues [29]. The hot 
spot in Figure 36 (axial view) can be explained by this effect. Furthermore, Figure 31 
shows a flatter irradiation surface than those of the other IOERT cases. This type of 
surface is probably related to biological fluid accumulation in that region and also 
affects the dose distribution (build-up effect, which shifts the dose distribution 
upwards) [8, 10]. PreCT images did not improve the estimation of the dose distribution 
compared to water assumption despite those images included the tissue heterogeneities. 
A better agreement was found when the air gap (and, therefore, the surface 
irregularities of the irradiated area) was included in the preoperative images. Most of 
those comparisons yielded a percentage of voxels fulfilling gamma criteria above 95%. 
A better matching in the chondrosarcoma case might be obtained by enlarging the air 
gap segmentation to include more volume of the excision cavity. No assessments 
concerning the tissue inside the applicator can be made as the TPS sets that region to 
the CT value of air automatically. The registration allowed resembling the patient 
position during IOERT in each preoperative CT image and placing the applicator in 
relation to the patient’s anatomy as in its corresponding intraoperative image. This step 
focused on rigidly aligning the bones close to the applicator bevel. The addition of the 
air gap (and, therefore, the surface irregularities of the irradiated area) provided good 
enough estimations of the actual IOERT dose distribution. Therefore, the dominant 
factor in IOERT dose estimation is the air gap and the surface irregularities. This 
assessment may not be valid, for example, in an IOERT scenario of rectal cancer since 
the tumour bed is very close to the sacrum or in breast cancer cases since the tumour 
bed is close to the shielding discs, ribs and the lung. In the evaluated IOERT cases, 
bones and lungs were not critical tissues as they were at a certain distance from the 
tumour bed. 
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In [10], the authors presented in vivo 2D dose distributions for pelvic IOERT. The 
images obtained from the radiochromic films placed on the irradiation surface showed 
a partial view of the 3D dose distribution. In our study, 3D dose distributions were 
obtained using two different methods: pencil beam and Monte Carlo. The gamma pass 
rates were higher when using the pencil beam estimation than with the Monte Carlo 
method for most cases. Pencil beam algorithm is subject to limitations with small 
irradiated volumes owing to the semi-infinite layer approximation and does not model 
backscatter radiation (for example, that produced by shielding discs) [49] (section 3.7). 
On the other hand, Monte Carlo algorithm better models electron-tissue interactions 
and consequently identifies subtle differences between the intraoperative CT images 
and the rest of images used in this study. 
Intraoperative CT images allow inspecting the protection assembly, which is the 
highest risk in IOERT [91] due to the lack of direct visual disc inspection, as it 
happened in the case of Patient 3 (Figure 26). However, transferring the patient to the 
CT simulator room to acquire intraoperative images may not be approved when a 
dedicated mobile LINAC is available in the OR. Other approaches to check the 
alignment between the shielding disc and the applicator/tumour bed may be using 2D 
portal images (MV) [4], ultrasound (US) images [6], X-ray images (acquired with a 
C-arm) [5], radiochromic films (for a posteriori analysis) [44] or using an applicator 
system that assures the protection assembly [92]. 
Our results have showed that the conventional assumption of having a flat irradiation 
surface of water at the end of the applicator can lead to erroneous assessments in 
IOERT. In breast cancer cases, this supposition can be valid [12] but not in the case of, 
for example, soft-tissue sarcomas in distal limbs (air gaps up to 5 cm, [93]) or in rectal 
cancer (irregular and/or concave surface, [10]). Intraoperative CT images would allow 
estimating the dose distribution of the actual IOERT scenario just before the 
radiotherapy treatment to adjust the IOERT settings or afterwards, to assess the 
outcome of the procedure with the registered IOERT parameters. These images can be 
acquired with a portable CT inside the OR or even with a LINAC that includes an on-
board kV CBCT [94]. The cost of these solutions may limit their use in most 
institutions. Other intermediate approaches to be further evaluated involve acquiring 
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2D projections with a C-arm of the whole setting (patient and applicator) [95] or 
surfaces with a conoscopic holography device [96] to update preoperative CT images 
with this intraoperative data. In this last solution it would be necessary to know the 
applicator pose in relation to the patient’s anatomy by using a tracking system [71]. All 
these technologies will allow updating the preoperative planning with actual dose 
estimation during the real IOERT procedure, facilitating decision making to the 
radiation oncologist and improving the available information for patient’s follow-up. 
5.5 CONCLUSIONS 
In this specific study, intraoperative CT images of real IOERT scenarios were acquired 
after transferring the patient from the OR to the CT simulator room before tumour bed 
irradiation. There were no complications by applying the modified IOERT protocol. 
The intraoperative images were used to estimate the actual 3D dose distribution in 
three out of the six evaluated IOERT cases. Those cases were discarded due to the 
presence of metal artefacts that substantially modified CT values. Gold standard 
estimations were compared to those calculated with their corresponding preoperative 
images. Results showed that preoperative CT images can be used to estimate the 
IOERT dose distribution under two conditions: knowing the applicator pose in relation 
to the patient’s anatomy (specifically to the bones) and incorporating information 
regarding the air gap between the end of the applicator and the tumour bed (and, 
therefore, the surface irregularities of the irradiated area). These IOERT dose 
distributions could be useful for patient follow-up and also for dose accumulation when 
EBRT is applied after an IOERT boost. 
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6 ASSESSMENT OF INTRAOPERATIVE 3D 
IMAGING ALTERNATIVES FOR IOERT DOSE 
ESTIMATION 
This chapter presents the specific study that evaluated several kV CT technologies 
other than CT simulators to acquire intraoperative images for estimating IOERT dose 
distribution with the actual condition. This research was related to the third specific 
objective of this thesis and was published in Zeitschrift für Medizinische Physik journal 
[94]. 
6.1 INTRODUCTION 
Regarding intraoperative imaging in IOERT, relevant recent studies include that of [4], 
who proposed 2D portal imaging to ensure alignment between the applicator and the 
shielding disc in breast cancer IOERT. In [97], the authors conducted a preliminary 
phantom study to evaluate the feasibility of using a C-arm with 3D imaging capability 
(ARCADIS® Orbic 3D, Siemens, Germany) to acquire images during IOERT, 
concluding that C-arm image quality was a major limitation. In [85], our group 
presented the first two clinical cases (Ewing sarcoma and undifferentiated sarcoma) in 
which intraoperative images were acquired using a CT simulator during IOERT. The 
patient was transferred from the operating room (OR) to the CT simulator room for 
acquiring an intraoperative CT image before the radiotherapy delivery in the treatment 
room. The 3D dose distribution of the actual treatment administered to the patient was 
calculated from the intraoperative CT image of the whole setting (patient and 
applicator) after superimposing the virtual applicator of the treatment planning system 
(TPS) on its actual position displayed in the CT image. Moreover, the dose was also 
estimated from their preoperative image after removing the tumour and its surrounding 
area as expected during the surgery and then aligning with the intraoperative CT image 
using deformable registration. Despite that preprocessing, there were still differences 
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between the dose distributions estimated with those preoperative images and those 
obtained from the intraoperative images (average difference of 5%). In [12] the authors 
pointed out that surface irregularities, simulated with a phantom, can significantly 
influence the IOERT dose distribution. Nowadays, IOERT is not entirely characterised 
since no intraoperative images of the actual scenario are routinely acquired during the 
treatment. This information would be useful not only for intraoperative planning but 
also for registering and evaluating the treatment administered to the patient. Following 
the approach of acquiring intraoperative images with CT simulators [85] has the 
limitation of the additional risks involved in transferring the patient to the CT simulator 
room. This setup may not be justified if a dedicated mobile electron accelerator is 
available in the OR. 
In external beam radiation therapy (EBRT), imaging is currently used for identifying 
differences in patient positioning or target position prior to treatment delivery (image-
guided setup correction). Many modern LINACs include integrated cone-beam CTs 
(CBCTs) that enable acquisition of 3D images with the patient in the treatment position 
that are then registered and compared with the planning CT. Moreover, these images 
can also be used to adapt the treatment plan depending on anatomical changes (weight 
loss, and tumour regression and displacement) during the radiotherapy course [98]. 
Several articles have focused on the feasibility of using CBCT images for dose 
calculation in EBRT and show that CBCT images cannot be used directly for dose 
estimation because their quality is lower than that of CT simulator images. For 
instance, dose calculations for treatment fields that have a larger size and different 
geometry than the phantom used in the calibration procedure for converting CT values 
into density resulted in dose errors larger than 5% (photons) [99]. Several approaches 
have been proposed in order to overcome this problem, including mapping CT values 
from planning CT to CBCT after rigid alignment [100], treatment field-specific 
look-up tables that convert CT values to density [99], a density override method based 
on segmenting water, air and bone [101], and measuring the scatter distributions from 
the first CBCT scan acquired for patient setup and applying scatter correction on 
subsequent CBCT scans acquired throughout the radiotherapy course [102].  
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To our knowledge, no studies have evaluated the use of kV CT technologies other than 
CT simulators, as is the case of CBCT devices or even portable multislice CT (MSCT) 
scanners, to acquire intraoperative images for estimating IOERT dose distribution with 
the actual conditions. In this study, we evaluate the feasibility and potential of using kV 
CT imaging systems other than CT simulators that can be integrated in the IOERT 
workflow to calculate radiation doses more accurately. 
6.2 METHODS 
In this section, we describe the CT imaging systems evaluated in this study and the 
methodology followed to assess their potential. The devices were selected based on 
their suitability for imaging during IOERT. The three CT scanners chosen comprised 
two portable systems and one device integrated in a conventional LINAC. Two 
commercial phantoms were acquired using the systems under evaluation to simulate 
two representative IOERT treatments. The same phantoms were also imaged in a 
conventional CT simulator and the dose distributions calculated from these studies 
formed the gold standards for our comparisons. 
CT imaging systems evaluated 
The three scanners with a kV CT imaging facility evaluated in this study were O-arm® 
Surgical Imaging (Medtronic, USA), TrueBeam™ STx (Varian Medical Systems, 
USA) and BodyTom® Portable CT Scanner (NeuroLogica Corporation, USA)             
(Figure 37).  
Other commercial C-arms that provide 3D imaging capability include ARCADIS® 
Orbic 3D (Siemens, Germany), BV Pulsera (Philips, The Netherlands) and Ziehm 
Vision FD Vario 3D (Ziehm Imaging Inc., USA). However, none of these devices was 
selected for this study owing to their reduced field of view (FOV). For instance, the 
reconstructed FOV size of Orbic 3D is 12 x 12 x 12 cm. 
The systems studied are described briefly below: 
- O-arm is a portable kV cone-beam scanner with a larger FOV than previously 
mentioned C-arms. Its sliding gantry enables lateral access and is closed for 
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image acquisition. It incorporates a 30 cm x 40 cm flat panel (Varian model 
PaxScan 4030 CB, amorphous silicon digital X-ray detector with a                         
1536 x 2048 pixel matrix and pixel pitch of 0.194 mm). The reconstructed 
FOV size is 20 cm (diameter) x 15 cm (height), with a matrix size of                       
512 x 512 x 192 and voxel size of 0.415 x 0.415 x 0.832 mm. 
 
  
Figure 37. CT scanners: (a) O-arm, (b) TrueBeam, (c) BodyTom, (d) CT simulator. 
O-arm has a gantry opening of 96.5 cm and its physical dimensions are 
249 x 81.3 x 202.2 cm (length x width x height). It is mainly used in spinal 
and orthopaedic surgeries. 
- TrueBeam combines the features of a LINAC and a kV CBCT. The on-board 
kV imager has a flat panel with a pixel matrix of 1536 x 2048 and an anti-
scatter grid on top of the scintillator layer. The 3D image FOV is 
46 x 46 x 16 cm for half-fan mode and 25 x 25 x 17 cm for full-fan mode, 
with a slice thickness ranging from 1 mm to 10 mm. The source-detector 
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distance is 150 cm. Its imaging tools are used to verify the patient’s position 
and tumour motion during treatment. 
- BodyTom is a portable MSCT scanner (32 slices) with an FOV of 60 cm 
(slice thickness from 1.25 mm to 10 mm, image matrix 512 x 512). This CT 
device works in helical or axial mode and moves along the bed to perform 
acquisitions. BodyTom has a gantry opening of 85 cm and physical 
dimensions of 256.5 x 104 x 205.7 cm (length x width x height). The device is 
optimised for use in spinal surgery, tumour removal and interventional 
radiology.  
All three devices fulfil the requirements for radiotherapy planning using scanners with 
wide apertures (at least 70 cm [103]). Of the three, BodyTom has the smallest gantry 
opening. Wide apertures are essential in IOERT, since abdominal surgical retractors or 
patient position (for example, lithotomy position) can prevent the patient from entering 
the gantry opening. 
These devices could be a good solution for intraoperative imaging in IOERT 
procedures with different workflows. O-arm and BodyTom could be moved into the 
OR in order to acquire the actual scenario before irradiating the patient with, for 
example, a mobile electron accelerator also located inside the OR. TrueBeam, on the 
other hand, enables intraoperative images to be obtained before radiation is delivered 
with its conventional LINAC. Using the TrueBeam approach, it would be necessary to 
transfer the patient from the OR to the LINAC room or alternatively the surgery could 
be performed in the LINAC facility, thus avoiding transportation. 
CT simulator 
The reference dose distributions were calculated from images acquired on an 
Aquilion™ Large Bore CT simulator (Toshiba, Japan). This multi-slice helical CT 
(16 slices) has a 70-cm FOV and a 90-cm gantry opening. This device is located in the 
Department of Radiation Oncology at Hospital General Universitario Marañón 
(Madrid, Spain) and its images are used for planning EBRT treatments. This CT 
simulator fulfilled the image quality tests of the Spanish Society of Medical Physics 
(http://www.sefm.es; results: noise 0.4%, field uniformity 3.8 HU, CT number for air      
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–980 HU and for water 3.8 HU [CT number accuracy], contrast resolution [low 
contrast resolution] 3.5% @ 2.5 mm and absence of artefacts) excepting the spatial 
resolution (high contrast resolution) test whose result (1 mm) was slightly higher than 
the manufacturer specification (0.6 mm). The spatial integrity [104] was                           
0.3 mm x 0.1 mm in the transaxial plane and 0.3 mm along the axial axis. 
Phantoms 
Two phantoms were used in this study: the model 062 electron density phantom and 
the model 057 triple modality 3D abdominal phantom, both from CIRS Inc. (USA) 
(Figure 38).  
The model 062 phantom enables conversion from CT number to physical density to 
calibrate each scanner, since this relationship varies between scanners [105]. 
Conversion factors were incorporated into the IOERT TPS to take account of tissue 
heterogeneity in dose calculation. The phantom consists of two nested discs (a head 
insert and a body disc) made from Plastic Water® (dimensions 33 x 27 x 5 cm) and 
several plugs (dimensions: 30 mm diameter x 50 mm length) of eight different tissue 
equivalent epoxy resins (lung inhale, lung exhale, adipose, breast 50% gland/50% 
adipose, muscle, liver, trabecular bone 200 mg/cc hydroxyapatite [HA] and dense bone 
800 mg/cc HA). A vial plug filled with sterilised water was placed at the centre of the 
phantom. 
The model 057 phantom makes it possible to simulate a small adult abdomen 
approximately from thoracic vertebrae T9/T10 to lumbar vertebrae L2/L3 and includes 
the liver, part of both kidneys, part of the lung surrounding the liver, portal vein, vena 
cava, abdominal aorta, spine and six ribs. This phantom was used to simulate two 
IOERT cases in order to compare dose distributions calculated from images acquired 
with the devices evaluated and the CT simulator (gold standard). The phantom housing 
is made from acrylonitrile butadiene styrene (ABS) and the rest of the phantom from 
proprietary gels. Its dimensions are 28 x 20 x 12.5 cm. 
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CT acquisitions 
Electron density and abdominal phantoms were scanned with each system. All CT 
acquisition parameters except matrix size were set to the same values for both 
phantoms in each scanner. Since the acquisition protocols offered a limited number of 
parameter combinations for each scanner, those selected were as similar as possible 
between scanners taking account of this restriction (Table 9). Tube voltage was 
selected according to typical CT protocols for radiotherapy planning. 
  
Figure 38. Phantoms: (a) model 062 electron density phantom, (b) model 057 triple modality 3D 
abdominal phantom. 
Table 9. CT acquisition parameters. 
 
Voltage 
(kVp) 
Exposure 
(mAs) 
Matrix size Voxel size (mm) 
CT simulator 120 300 
512 x 512 x 141a 
512 x 512 x 251b 
0.6 x 0.6 x 1.0 
     
O-arm 120 298 512 x 512 x 192 0.4 x 0.4 x 0.8 
     
TrueBeam 
(half-fan 
mode) 
125 262 512 x 512 x 81 0.9 x 0.9 x 2.0 
     
BodyTom 
(helical, soft 
tissue filter) 
120 295 
512 x 512 x 136a 
512 x 512 x 128b 
1.2 x 1.2 x 1.3 
a Electron density phantom. 
b Abdominal phantom.
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Conversion of the CT number to physical density 
Electron density phantom images were used to calibrate the conversion from CT 
number to physical density in each system. Cylindrical regions of interest (ROIs) of 
20 mm diameter x 20 mm length were contoured centred on each plug, on the electron 
density head insert, on the electron density body disc, on the vial plug filled with 
sterilised water and outside the phantom (air). The region of interest (ROI) selected in 
the dense bone (800 mg/cc HA) equivalent electron density plug was smaller                 
(6 mm diameter x 20 mm length) because the insert contains a 10-mm core of bone 
equivalent surrounded by water-equivalent material. 
An in-house implementation of the stoichiometric calibration [50] was applied to the 
data from the electron density phantom to obtain the CT numbers specific for each 
scanner of seven PENELOPE materials (dry air, lung, adipose tissue, striated muscle, 
muscle-equivalent liquid with sucrose, B100 and cortical bone) with known physical 
density and chemical composition (section 3.8). PENELOPE software is used to 
perform Monte Carlo simulation of coupled electron-photon transport and of electron 
and positron interactions [106]. The chemical composition of these PENELOPE 
materials closely follows the International Committee for Radiological Units (ICRU) or 
the International Commission on Radiological Protection (ICRP) standard chemical 
composition for biological tissues. B100 is a tissue substitute that has a chemical 
composition close to that of soft bone. The least squares fit of the stoichiometric 
calibration assumes that CT numbers are in HU so that X-ray attenuation of distilled 
water and attenuation of air at standard pressure and temperature are defined as 0 HU 
and –1000 HU respectively. The physical density and chemical composition of the 
materials of the electron density phantom were provided by CIRS Inc. The CT numbers 
of those seven PENELOPE materials and their physical density (calibration curve) 
were then entered into the IOERT TPS.  
In the case of the O-arm scanner, two modifications to the procedure were necessary to 
convert the CT number to physical density. First, electron density phantom CT image 
values were linearly transformed, since the CT numbers for air and distilled water were 
different from –1000 HU and 0 HU respectively. Second, as the FOV acquired by the 
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O-arm covered only the electron density head insert, eleven ROIs were drawn on that 
image instead of the twenty ROIs segmented on the images from the other scanners. 
These adjustments were necessary to perform the stoichiometric calibration.  
Several profiles were drawn on the electron density phantom images after rigid 
alignment of the studies from all the scanners (manual registration using the CT 
simulator image as a reference) in order to evaluate the variations in CT number within 
each plug between the CT simulator and each of the CT devices under evaluation. 
Dose distribution evaluation 
Two IOERT cases were simulated on the images from the abdominal phantom using 
the TPS radiance (GMV, Spain) [3]: a pancreatic tumour and a soft-tissue sarcoma in 
paraspinal muscle. Abdominal images were resampled to 1.5-mm isotropic voxel size 
and then aligned (automatic rigid registration with normalised mutual information as 
cost function) using the CT simulator image as a reference. This procedure enabled us 
to place the IOERT applicator in the same position for all of the scanners. Dose 
distributions were calculated using the Monte Carlo algorithm (error tolerance 1%) 
[50] and doses were not scaled to a normalised value (section 5.2). The pencil beam 
algorithm was not used in this study as it is subject to limitations with small irradiated 
volumes owing to the semi-infinite layer approximation and does not model 
backscatter radiation (for example, that produced by shielding discs) [49]. 
In the case of the pancreatic tumour, the pancreas and liver were segmented and the CT 
numbers of the voxels inside those masks were set to air in order to simulate tumour 
resection and liver displacement respectively. Surgical access was also simulated in the 
TPS. Tumour bed (clinical target volume [CTV]) and organs at risk (OARs: aorta, vena 
cava, left kidney and spinal cord) were also contoured. The IOERT parameters were 
applicator diameter 50 mm, bevel angle 0º, energy 6 MeV and a prescribed dose of 
15 Gy at a 90% isodose (Figure 39(a)). 
In the case of the paraspinal muscle sarcoma, the procedure followed was similar, 
namely, surgical access, tumour resection and segmentation of the CTV and OARs 
(right kidney and spinal cord). To protect the right kidney, two shielding discs were 
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placed virtually between the CTV and the right kidney. A brass disc (thickness 3 mm, 
diameter 60 mm, physical density 8.6 g/cc) was placed close to the right kidney and a 
Teflon disc (thickness 3 mm, diameter 60 mm, physical density 2.2 g/cc) was 
positioned above the brass disc and towards the CTV to reduce backscattering radiation 
from the brass disc. The IOERT parameters were applicator diameter 50 mm, bevel 
angle 15º, energy 6 MeV and a prescribed dose of 12.5 Gy at a 90% isodose                 
(Figure 39(b)). 
  
Figure 39. Simulated IOERT cases: (a) pancreatic tumour (CTV in green, aorta in red, vena cava in 
blue, left kidney in yellow and spinal cord in purple), (b) paraspinal muscle sarcoma (CTV in blue, right 
kidney in yellow, spinal cord in purple and shielding discs in brown). Clinical axis in purple, transverse 
axis at depth of 10 mm in red and transverse axis at depth of 25 mm in green. R (right) and L (left). 
Dose distributions calculated from images obtained with the devices under evaluation 
were compared with the gold standard (CT simulator) in terms of the gamma index 
(section 3.5). An acceptance criteria of 3%/3 mm and also of 5%/2 mm for dose values 
greater than either 10% or 70% (to focus on high dose regions) were used in the 
comparisons as in section IOERT dose distributions (section 5.2). Cumulative dose-
volume histograms (DVHs), percentage of depth dose (PDD) profiles and transverse 
dose profiles (TDPs) at several depths were also obtained for both IOERT cases and all 
scanners (Figure 39). 
In the case of the O-arm scanner, the CT image of the abdominal phantom was first 
transformed by applying the same adjustment used with the electron density phantom 
in order to fix CT numbers. 
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6.3 RESULTS 
Figure 40 illustrates the nonlinear CT number to physical density conversions for all 
devices. The curves are similar until the inflection point at around 100 HU. For higher 
CT numbers, the physical density differs between scanners.  
Figure 41 shows three different profiles for each CT scanner, two on a transaxial view 
and one along the axial axis. O-arm intensity values presented an offset (corrected for 
stoichiometric calibration and dose estimation as explained in section 6.2), and the 
intensity difference between materials was smaller than with the CT simulator. 
TrueBeam profiles were closer to the CT simulator profiles than those from the O-arm, 
although there was a smooth change in homogeneous areas such as Plastic Water 
(Figure 41(a)) and incorrect CT values in trabecular bone (Figure 41(b)). On the other 
hand, BodyTom CT numbers were quite similar to those of the CT simulator except for 
a disagreement in the dense bone values (Figure 41(b)).  
 
Figure 40. Calibration curves for the transformation of CT number to physical density for each CT 
scanner. 
Two IOERT cases were simulated with the TPS using the images from the abdominal 
phantom. The registration results for all these CT images were checked by visual 
inspection. The FOV acquired by the O-arm did not cover the whole abdominal 
phantom, but the treatment volume and surrounding tissues were sufficiently covered 
to obtain comparable results. Figure 42 and Figure 43 show the dose distributions and 
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the cumulative DVHs for both scenarios respectively. In the case of the pancreatic 
tumour, the results for the different CT devices are quite close to the gold standard 
except for the O-arm, whose cumulative DVHs differ slightly from the reference. The 
DVHs of the left kidney and the spinal cord were not displayed since the 10% of the 
volume of those organs would absorb at least a dose of 33 cGy in all devices. In the 
case of the paraspinal muscle sarcoma, the disagreement with the gold standard is 
slightly higher than in the case of the pancreatic tumour for all scanners and is more 
noticeable in the spinal cord cumulative DVH calculated using the O-arm image. The 
DVH of the right kidney was not shown since the 10% of the volume of this organ 
would get at least a dose of 28 cGy in all devices. Figure 44 shows the PDDs 
corresponding to both IOERT scenarios with the characteristic dose gradient of 
electron beams. The behaviour of the PDDs is similar to that of the DVHs. Dose 
differences with respect to the CT simulator increased with depth. On the other hand, 
the TDPs at 10 mm are similar to the CT simulator TDPs, except for the O-arm TDP 
from the case of the paraspinal muscle sarcoma (Figure 45). Further analysis of this 
second IOERT case shows that the TDP at 25 mm went through the spinal cord, the 
shielding discs and the right kidney (Figure 39(b), Figure 45(c)). The percentage of 
dose is zero for the O-arm and higher for the TrueBeam and the BodyTom, but lower 
than the gold standard in all cases. Table 10 and Table 11 include the percentage of 
voxels fulfilling selected gamma criteria (3%/3 mm and 5%/2 mm) for the pancreas 
and the paraspinal muscle respectively. Regarding the O-arm, the percentage is below 
75% in both IOERT cases. TrueBeam showed values above 95% in all cases except in 
two comparisons, yielding gamma pass rates of 91.7% and 94.4% in those specific 
scenarios (in the pancreatic tumour, when voxels with a dose higher than 10% and 
gamma criteria of 3%/3 mm were selected, and in the paraspinal muscle, when voxels 
with a dose higher than 10% and gamma criteria of 5%/2 mm were chosen 
respectively). BodyTom yielded better results with more than 98% of voxels fulfilling 
the gamma criteria in all comparisons.  
Finally, Table 12 shows the CT numbers of the seven PENELOPE materials obtained 
in the stoichiometric calibration and the CT numbers of several ROIs (circle of radius 
3.5 mm) drawn in the abdominal phantom for each scanner. In the case of the O-arm, 
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the CT numbers of the abdominal phantom do not follow the correspondence with 
those of PENELOPE materials. For instance, the CT numbers of rib and vertebra ROIs 
should be below those of B100 for the O-arm device, as is the case for the CT 
simulator, TrueBeam and BodyTom. 
 
 
Figure 41. Electron density phantom profiles for each CT scanner: (a) Lung inhale - Plastic Water - 
Lung exhale, (b) Trabecular bone 200 mg/cc HA - Plastic Water - Dense bone 800 mg/cc HA,                      
(c) Air - Breast 50% gland / 50% adipose - Air. Values shown for O-arm profiles are not corrected. 
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Figure 42. Axial view of dose distributions. (a) CT simulator, (b) O-arm, (c) TrueBeam, (d) BodyTom. 
Pancreatic tumour (top) and paraspinal muscle sarcoma (bottom). Right kidney (yellow), spinal cord 
(purple), and shielding discs (brown). R (right) and L (left). 
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Figure 43. Cumulative DVHs. In the case of pancreatic tumour, (a) tumour bed (CTV), (b) aorta and 
(c) vena cava. In the case of the paraspinal muscle, (d) CTV and (e) spinal cord. 
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Figure 44. PDDs in the case of the (a) pancreatic tumour and (b) paraspinal muscle sarcoma. 
 
 
 
 
Figure 45. TDPs at a depth of 10 mm in the case of the (a) pancreatic tumour and (b) paraspinal 
muscle sarcoma. TDPs at a depth of 25 mm in the case of the (c) paraspinal muscle sarcoma (shielding 
discs were at a position –30 mm). 
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Table 10. Percentage of voxels fulfilling the gamma criteria for the case of pancreatic tumour.a 
 3%/3 mm 5%/2 mm 
 Dose > 10% Dose > 70% Dose > 10% Dose > 70% 
O-arm 52.3 70.8 45.9 68.7 
TrueBeam 91.7 97.9 95.9 99.7 
BodyTom 100.0 100.0 100.0 100.0 
a Percentages of voxels fulfilling the gamma criteria higher than 95% are highlighted in bold. 
 
Table 11. Percentage of voxels fulfilling the gamma criteria for the case of the paraspinal muscle 
sarcoma.a 
 3%/3 mm 5%/2 mm 
 Dose > 10% Dose > 70% Dose > 10% Dose > 70% 
O-arm 43.3 55.6 37.4 47.8 
TrueBeam 98.1 97.7 94.4 97.0 
BodyTom 98.7 99.9 99.1 100.0 
a Percentages of voxels fulfilling the gamma criteria higher than 95% are highlighted in bold. 
 
Table 12. CT numbers of the seven PENELOPE materials obtained in the stoichiometric 
calibration and CT numbers of several ROIs drawn in the abdominal phantom for each scanner. 
  
CT 
Simulator 
O-arm 
(corrected 
values) 
TrueBeam BodyTom 
PENELOPE 
materials 
Dry air –998.9 –998.9 –998.9 –998.9 
Lung –701.7 –702.3 –701.6 –701.4 
Adipose tissue –131.4 –72.3 –81.7 –102.2 
Striated muscle 32.4 32.8 34.6 34.5 
Muscle-equivalent
liquid with sucrose
85.4 98.8 96.2 91.5 
B100 759.7 380.9 550.4 683.9 
Cortical bone 1526.2 741.5 1055.2 1331.0 
      
 
Abdominal 
phantom 
 
Soft tissue 43.6 376.0 66.5 43.7 
Liver 98.3 393.7 106.2 101.0 
Rib 495.6 499.5 477.0 471.9 
Vertebra 516.7 820.7 473.9 466.1 
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6.4 DISCUSSION 
This is the first study to assess three kV CT imaging systems other than CT simulators 
with the ability to acquire intraoperative images in the IOERT framework. Since the 
evaluation focused on dose distribution rather than imaging performance for CT 
simulators, parameters such as image noise, contrast resolution, spatial resolution and 
spatial integrity [104] were not assessed.  
TrueBeam and BodyTom showed very good agreement (BodyTom slightly better than 
TrueBeam) with the reference, with only small differences in terms of DVH, PDD, 
TDP at a specific depth and specific gamma criteria. This was not the case of the 
O-arm, which had a lower percentage of voxels fulfilling the gamma criteria. The main 
applications of O-arm device are spinal and orthopaedic surgeries, not the estimation of 
dose distributions. As for PDDs, differences were more noticeable at greater depths. 
This finding is consistent with previously published data for an energy level of 6 MeV 
[107]. Higher disagreement was observed for the case of the paraspinal muscle 
sarcoma (Figure 45(c)): no dose is calculated for the O-arm and a lower value than the 
reference dose is calculated for the TrueBeam and BodyTom. As the spinal cord is 
centred at 25 mm, the underdosage in the PDDs (Figure 44) and in the TDPs                 
(Figure 45(c)) led to underestimation of the spinal cord DVHs (Figure 43). 
Nevertheless, that depth was out of the therapeutic range and close to the end of the 
practical range of all PDDs. The low dose in the spinal cord (paraspinal muscle 
sarcoma) with the O-arm was due to the wrong correspondence between the CT 
numbers of the abdominal phantom and those of the PENELOPE materials. In the case 
of the O-arm, CT numbers of the vertebra were higher than the values of the cortical 
bone. In the rest of devices, CT numbers of the vertebra were much lower than the 
values of the cortical bone. The number of electrons that would interact with the spinal 
cord would be lower in the case of the O-arm than in the rest of devices since physical 
densities assigned to the vertebra would be higher than the values for the cortical bone, 
thus reducing the dose in the spinal cord. The gamma criteria were only affected in the 
O-arm case.  
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Image artefacts are a major source of error when estimating dose distribution. They 
imply inconsistency between CT numbers in the reconstructed image and the true 
attenuation coefficients of the tissues. Two of the devices evaluated in this study are 
CBCT systems. Although CBCT has a lower imaging dose than MSCT, it has 
disadvantages such as increased scattered radiation (increased noise, decreased contrast 
resolution, shadows, streaks and cupping artefacts), truncation artefacts (a rim of high-
attenuation values combined with characteristic streaking) and movement artefacts; in 
addition, it does not provide actual HU [108, 109]. Although [110] established a strong 
correlation between HU in MSCT and CT numbers in CBCT, their findings were based 
on the inaccurate assumption of a uniform relationship between X-ray attenuation and 
CT number through the CBCT image volume. Scattered radiation and beam hardening 
lead to CT number inhomogeneity [111]. On the other hand, since the electron density 
phantom and abdominal phantom differ in their dimensions and composition, scatter 
produced from both phantoms may affect CT numbers differently. In [112], the authors 
found that adding scatter longitudinally (by increasing phantom length) has a 
noticeable effect on CT number values (for example, increasing up to approximately 
260 HU in high-density materials when modifying phantom length from 5 cm to scan 
length [16 cm]), although this effect is much less profound than when adding radial 
scatter (by changing phantom diameter). Once the scan length was covered, the 
influence of the longitudinal scatter on CT numbers was reduced. These images were 
acquired using On-Board ImagerTM (OBI, Varian Medical Systems) version 1.4              
(half-fan mode). In [113], the authors indicated that full scatter condition is necessary 
when obtaining the conversion from CT numbers to density for a CBCT (OBI, Varian 
Medical Systems) in order to have a better dose estimation using photon beams, 
especially in regions with large inhomogeneity. There is an extended version of the 
electron density phantom used in our study specifically designed for CBCTs (model 
062MA). This phantom (dimensions 33 x 27 x 25 cm) contains other slabs of Plastic 
Water that allow full scatter of cone-beam X-rays. A stoichiometric calibration with 
this type of phantom together with a reconstruction method that included beam 
hardening and scatter corrections achieved a better CT number accuracy in CBCT 
images of head and neck phantoms using OBI version 1.4 (Varian Medical Systems) 
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[114]. Our study did not include full scatter condition for the CBCTs devices (O-arm 
and TrueBeam). Nevertheless, TrueBeam results were good enough as the percentage 
of voxels fulfilling gamma criteria was above to 95% for most cases. In the case of the 
O-arm, acquiring the extended version of the electron density phantom would not fix 
its low gamma pass rates since it is not the main cause for that mismatch. Even after 
the CT number adjustment, O-arm values of analogous tissues in the electron density 
phantom and abdominal phantom images differ. This mismatch may be associated with 
the truncation artefact. Neither the electron density phantom (dimensions                           
33 x 27 x 5 cm) nor the abdominal phantom (28 x 20 x 12.5 cm) was completely 
scanned with the O-arm owing to its reduced FOV. CT reconstruction algorithms 
assume that the detector collects projection data of the whole object in all acquisition 
angles. Incomplete data from the object leads to truncation artefacts. In this situation, 
true linear attenuation coefficients cannot be calculated and it is not possible to obtain 
actual HU [115]. In fact, CT numbers from CBCT images of the same object differ 
depending on the FOV [116]. Any object that does not fit within the scanner FOV 
(large patients, retractors or the articulated arm that fixes the position of the applicator) 
can potentially generate truncation artefacts and thus lead to incorrect dose 
distributions.  
While our analysis of imaging possibilities during IOERT is encouraging, several 
issues still need to be addressed. Firstly, reproducibility and long stability of the CT 
number to physical density conversion for each evaluated device have not been 
assessed. In this study, images of the electron density phantom and the abdominal 
phantom were acquired with the same acquisition parameters (excepting matrix size) 
and within the same day for each evaluated device. This is important since tube 
voltage, collimation and filter type affect CT values (Synergy X-ray volume imaging 
[XVI], Elekta AB, Sweden) [99] while exposure has a small impact (Trilogy system, 
Varian Medical Systems) [117]. In [118], the authors pointed out that the stability of 
the calibration curve to transform CT number into density is system-dependent. For 
example, the XVI system mounted on a Elekta Synergy LINAC should be calibrated 
periodically because of a possible change in sensitivity of the flat panel detector 
(1-year evaluation period) [118]. On the other hand, the OBI calibration curve of the 
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Varian Trilogy LINAC showed very slight changes (6-month evaluation period) [119]. 
Recommendations from the Task Group 66 (TG–66) AAPM establish that the CT 
number to density conversion should be evaluated at least annually or after a scanner 
calibration in the case of CT simulators [104]. Secondly, in the case of the pancreatic 
tumour, two shielding discs were virtually placed between the CTV and the right 
kidney. These protections would generate metal artefacts (severe streaking) that will 
substantially modify CT numbers, so the dose distribution estimated with 
intraoperative CT images of this IOERT scenario would be incorrect. Surgical 
retractors also produce this type of artefacts. Some ideas to get through this problem 
could be replacing the CT numbers that are affected by the metal artefact by their 
corresponding CT numbers in the preoperative images or, in the case of the retractors, 
removing these devices from the surgical scenario or replacing them with other surgical 
instruments that do not generate this artefact just before acquiring the intraoperative 
image. Despite these drawbacks, intraoperative images would provide useful 
information about the actual treatment field for radiation oncologists and medical 
physicists. 
6.5 CONCLUSIONS 
We assessed three kV CT imaging systems that can be used to acquire intraoperative 
images and thus update IOERT according to actual conditions. The evaluation was 
based on the comparison of dose distributions calculated with phantom images 
obtained for each of the CT devices under evaluation and for a CT simulator (gold 
standard). The results reveal that a portable CT (BodyTom) and even a LINAC with 
on-board kV CBCT (TrueBeam) would be suitable for this purpose. Owing to its 
reduced FOV (leading to truncation artefacts), the O-arm system produced the worst 
matching. Our results show the ability of the other two intraoperative imaging CT 
devices (TrueBeam and BodyTom) to estimate the IOERT dose. This information 
would be useful for intraoperative planning and for registering and evaluating the 
treatment administered to the patient. 
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7 DISCUSSION 
In this thesis, we have proposed and evaluated new approaches to improve the existing 
information on the actual IOERT treatment delivered to the patient. Currently, this 
procedure is based on assumptions such as the irradiated tissue is equivalent to water in 
both stopping power and scattering power, and the bevel is in contact with the patient’s 
surface (thus the end of the applicator is parallel to the surface). However, surgical 
access, tumour resection, patient’s heterogeneous tissues and IOERT treatment set-up 
may invalidate these assumptions.  
Several studies have pointed out the need of intraoperative imaging to check applicator 
placement and to calculate 3D dose distributions before radiation delivery, and the 
need of further research to evaluate the effect of not fulfilling previous IOERT 
assumptions [43, 52]. In-vivo dosimetry allows point and 2D dose measurements to 
register the actual treatment administered to the patient. For instance, in vivo 2D dose 
distributions obtained from radiochromic films have shown results along the irradiated 
surface in pelvis IOERTs that did not correspond to expected values [10]. However, no 
data of the actual IOERT 3D scenario is available (for example, the applicator pose in 
relation to the patient’s anatomy or the irregularities in the irradiated surface) and 
consequently only a rough approximation of the real IOERT treatment administered to 
the patient can be estimated. This information would be useful for patient follow-up, 
for dose accumulation when EBRT is applied after an IOERT boost and for prospective 
trials such as ELIOT trial where the authors pointed out the difficulty when delimiting 
the suitable coverage of the tumour bed.  
Our first specific study focused on assessing the feasibility of using a multi-camera 
optical tracking system (OTS) to obtain the applicator pose in IOERT scenarios. 
Results showed that the accuracy of the applicator pose was below 2 mm in position 
(mean error of the bevel centre) and 2º in orientation (mean error of the bevel axis and 
the longitudinal axis), which are within the acceptable range proposed in the 
recommendation of Task Group 147 (TG–147) (commissioned by the Therapy 
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Committee and the Quality Assurance and Outcomes Improvement Subcommittee of 
the AAPM to study the localization accuracy with non-radiographic methods such as 
infrared systems in external beam radiation therapy). This may be considered to be a 
lower limit as the study was carried out with an idealised and simplified patient. The 
advantages of this approach are that applicator movements are tracked and 3D dose 
distributions can be updated taking account of the pose of the applicator before 
radiation delivery. The multi-camera OTS was also tested in real IOERT scenarios by 
our group [120]. A preoperative CT image with several radiopaque markers on the 
patient’s surface (for physical-to-image space registration) was acquired just before 
IOERT. There were no complications related to the integration of applicator tracking 
into the IOERT protocol. There is another approach to obtain applicator pose as that 
recently described in [95]. The authors (in collaboration with our group) presented a 
phantom study where the applicator pose was estimated from C-arm projections of the 
IOERT scenario (applicator placed on an extremity phantom). The limitation of our 
multi-camera OTS solution is that the actual pose of applicator is superimposed on a 
patient’s preoperative image, thus influencing applicator pose accuracy. The solution 
with C-arm projections would allow updating the preoperative image with 
intraoperative data but another applicator pose would need extra projections, thus more 
radiation exposure to the patient/medical personnel. Our solution could be combined 
with an intraoperative CT image and that data would also be used to estimate 3D dose 
distributions. Hence, the rest of the thesis focused on intraoperative CT imaging in 
IOERT scenarios. 
Regarding the second specific objective of this thesis, there were no complications in 
the whole procedure related to the transport step using the subtable and its stretcher, or 
the acquisition of intraoperative CT images in the CT simulator room (for example, 
anaesthetic stability or other clinical relevant observations). The 3D dose distributions 
estimated with the intraoperative images (gold standard) showed differences with 
respect to those corresponding to water assumption (for example, gamma pass rates of 
38.9% in the worst case [Monte Carlo, 3D gamma criteria of 5%/2 mm and dose values 
greater than 70%]). From all the presented experiments we concluded that preoperative 
CT images can be used to estimate the IOERT dose distribution under two conditions: 
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knowing the applicator pose in relation to the patient’s anatomy (specifically to the 
bones) and incorporating information regarding the air gap between the end of the 
applicator and the tumour bed (and, therefore, the surface irregularities of the irradiated 
area). Moreover, the dominant factor in IOERT dose estimation is the air gap and the 
surface irregularities, not tissue heterogeneities. This assessment may not be valid, for 
example, in rectal cancer IOERT since the tumour bed is very close to the sacrum or in 
breast cancer cases where the tumour bed is close to the shielding discs, ribs and lung. 
In the evaluated IOERT cases, bones and lungs were not critical tissues as they were at 
a certain distance from the tumour bed. The limitations of acquiring intraoperative CT 
images for estimation 3D dose distributions are metal artefacts caused by shielding 
discs (breast cancer cases) or surgical retractors that substantially modified HU. A 
solution would be replacing the incorrect CT values with the corresponding ones from 
the registered preoperative image. 
Our third specific study focused on assessing several kV CT technologies other than 
CT simulators to acquire intraoperative images for estimating IOERT dose distribution. 
That would be necessary when a mobile electron LINAC was available in the OR as 
transferring the patient to the CT simulator room could not be approved. Our results 
with an abdominal phantom revealed that a portable CT (BodyTom) and even a 
LINAC with on-board kV CBCT (TrueBeam) would be suitable for this purpose. 
Using the TrueBeam approach, it would be necessary to transfer the patient from the 
OR to the LINAC room or alternatively the surgery could be performed in the LINAC 
facility, thus avoiding transportation. Intraoperative CT images could be used to 
register the actual treatment administered to the patient or combined with an OTS when 
the applicator is not acquired in those images. The cost of these devices is the variable 
that may limit their use in most institutions. Other intermediate approach would be 
acquiring the irradiation surface to update preoperative CT images with this 
intraoperative data or even, looking at the results of the second specific study, to 
estimate dose distributions from a new image that is set to air above that surface                  
(–1000 HU) and to water below that surface (0 HU). This surface could be acquired 
with a structured-light 3D scanner [121] (phantom study with a torso and several 
objects) or with a conoscopic holography device [96] (phantom study done by our 
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group with a breast phantom, a container with bloody fluid and other phantoms). In 
these solutions it would be necessary to know the applicator pose in relation to the 
patient’s anatomy by using a tracking system. 
In IOERT, there is not a general approach that allows registering the whole 
radiotherapy procedure in all scenarios. As previously mentioned, intraoperative CT 
images are considered to be the gold standard to estimate dose distributions but CT 
images that include shielding discs (for example, in breast IOERT) or retractors cannot 
be directly used for dose estimation due to metal artefacts. For instance, in those breast 
cancer cases, an applicator system that assures the alignment of 
applicator/target/shielding discs [92] would reduce the air gap between the end of the 
applicator and the tumour bed. However, this approach would not provide data 
regarding dose distribution. Research is necessary in IOERT to know the actual 
treatment administered to the patient and put IOERT and EBRT at the same level in 
terms of planning and dose recording.  
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8 CONCLUSIONS 
The main contributions and conclusions of this thesis are as follows: 
 A multi-camera optical tracking system was proposed to obtain the applicator 
pose in IOERT since this complex clinical scenario obstructs the required line-
of-sight between the tracked objects and the cameras. Errors when testing this 
solution in an end-to-end phantom study were 1.8 mm in position (mean error 
of the bevel centre), 1.6º in rotation around the bevel axis (mean error) and 
0.7º in rotation around the longitudinal axis (mean error). These values were 
within the acceptable range proposed in the TG–147 recommendation. 
 We have demonstrated that acquiring intraoperative CT images with a CT 
simulator when transferring the patient from the OR to the LINAC room was 
feasible. These intraoperative images, when metal artefacts were not present, 
allowed estimating 3D dose distributions. 
 We found that gamma pass rates improved from 38.9% to 96.2% (worst case) 
mainly when adding the air gap between the end of the applicator and the 
tumour bed (and, therefore, the surface irregularities of the irradiated area) to 
the preoperative images. 
 In IOERT scenarios where bones and lungs are at a certain distance from the 
tumour bed, we also demonstrated that the dominant factor in dose estimation 
is the air gap between the bevel and the irradiated surface, not tissue 
heterogeneities. 
 We proposed three kV CT imaging systems other than CT simulators to 
acquire intraoperative images in the IOERT framework. A portable CT 
(BodyTom) and even a LINAC with on-board kV CBCT (TrueBeam) showed 
gamma pass rates greater than 95% in most comparisons. On the other hand, 
an O-arm system revealed worst results (below 75% in both simulated IOERT 
cases) due to its reduced FOV (leading to truncation artefacts). Therefore, the 
first two devices would be suitable for estimating 3D dose distributions in 
IOERT scenarios. 
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9 FUTURE LINES 
Possible future lines of research derived from this thesis are as follows: 
 To include a figure of merit of the tracking process for the interactive 
assessment of the data collected by the multi-camera OTS.  
 To explore correcting intraoperative images that are affected by metal 
artefacts to estimate 3D dose distributions. One approach is to replace 
uncorrected CT values with the corresponding ones from the registered 
preoperative image or even with the mean CT values of certain regions from 
the contralateral side. 
 To carry out a phantom study to evaluate the error when estimating the 3D 
dose distribution with an image created from the surface of the tumour bed. 
This is an intermediate solution between the conventional assumption of 
having just water at the end of the applicator and acquiring an intraoperative 
CT image. 
 To assess the influence of adding scatter to the images of the on-board kV 
CBCT (TrueBeam) and its effect on IOERT doses. 
 To assess the reproducibility and long stability of the CT number to physical 
density conversion for the portable CT (BodyTom) and the on-board kV 
CBCT (TrueBeam). 
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